Use of hypnotics and sedatives

RX_N05C

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — N05C 1 out of 7 registries used, show all original rules.	100217
4. Check minimum number of events Min. number of events 3	100217
5. Include endpoints None	100217
6. Filter based on genotype QC (FinnGen only)	89185

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF5

NAME	RX_N05C
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	N05C
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Use of hypnotics and sedatives based on the number of shared cases.

Similar with more cases:

Any prescribed medicine buy

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	791068	467501	316347
Only index persons	649689	398173	251516
Unadjusted period prevalence (%)
Whole population	11.52	13.39	8.84
Only index persons	12.69	14.64	9.60
Median age at first event (years)
Whole population	57.02	58.33	54.85
Only index persons	54.22	55.71	51.85

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	89185	53099	36086
Unadjusted period prevalence (%)	17.92	18.85	16.55
Median age at first event (years)	52.28	50.25	55.26

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
67801: Matched controls
387244

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

322.2

7994

28774

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.2

321.8

3129

8217

SPAT1254

SPAT

Administration of medicine

1.7

320.6

7975

28722

N02AC04

ATC

dextropropoxyphene; oral

2.7

318.1

1990

4222

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.5

314.3

2384

5588

J01FA10

ATC

azithromycin; systemic

1.4

312.8

34639

167516

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

312.6

13463

55070

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

312.2

3379

9273

AA400

NOMESCO Finland

Electroconvulsive therapy

6.5

311.2

656

578

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.1

310.5

696

659

B01AB05

ATC

enoxaparin; parenteral

1.4

310.4

17823

77096

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

309.9

10011

38440

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

308.2

17656

76320

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.8

307.7

3961

8366

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

307.7

7992

27111

N02BF01

ATC

gabapentin; oral

2.2

307.7

7148

20113

H03AA01

ATC

levothyroxine sodium; systemic

1.6

307.7

13326

52122

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.5

307.7

1250

1118

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

29317

117344

R02

ICPC

Shortness of breath/dyspnoea

1.7

307.7

8182

28230

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

6.0

307.7

2396

2355

J01MA02

ATC

ciprofloxacin; systemic

1.6

307.7

24791

100474

N03AX11

ATC

topiramate; oral

3.1

307.7

1691

3160

F10.25

ICD-10 Finland

Alcohol dependence continuous use

5.4

307.7

1595

1710

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

307.7

9195

30500

F10.20

ICD-10 Finland

Alcohol dependence currently independent

6.4

307.7

2035

1871

N05CB02

ATC

barbiturates in combination with other drugs

4.7

307.7

1151

1432

N05AA01

ATC

chlorpromazine; systemic, rectal

8.0

307.7

1231

890

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.1

307.7

6523

9716

F51

ICD-10 Finland

Nonorganic sleep disorders

3.7

307.7

3974

6412

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.1

307.7

7077

14146

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.7

307.7

7160

9583

N06AX03

ATC

mianserin; oral

8.4

307.7

5288

3856

M01AB05

ATC

diclofenac; systemic, rectal

1.5

307.7

42351

200990

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.7

307.7

1551

2417

188

Kela drug reimbursment

Psychosis requiring demanding treatment

6.7

307.7

857

738

N05AC02

ATC

thioridazine; oral

5.1

307.7

1433

1640

R4110

NOMESCO Finland

Physiotherapy

1.5

307.7

16499

67361

R51.80

ICD-10 Finland

Headache

1.7

307.7

9686

34890

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

307.7

32350

151811

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

6.3

307.7

1551

1426

H02AB07

ATC

prednisone; oral

1.7

307.7

7792

27500

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

6.2

307.7

1035

973

N06AX17

ATC

milnacipran; oral

5.4

307.7

820

871

N05BA02

ATC

chlordiazepoxide; systemic

8.7

307.7

2384

1610

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.7

307.7

2842

6278

A02BC02

ATC

pantoprazole; systemic

2.0

307.7

46726

204791

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.3

307.7

11948

23422

N06AX11

ATC

mirtazapine; oral

6.9

307.7

39811

66474

N06AX22

ATC

agomelatine; oral

4.9

307.7

2160

2576

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

307.7

13408

51251

N06AA09

ATC

amitriptyline; systemic

3.9

307.7

7943

12828

Z3231

NOMESCO Finland

Registered nurse

1.6

307.7

16703

64640

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

307.7

9472

34798

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

6.9

307.7

755

635

M01AH01

ATC

celecoxib; oral

1.7

307.7

10617

37291

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

6.4

307.7

1000

904

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

307.7

10020

34491

N05CF01

ATC

zopiclone; oral

34.2

307.7

52718

35917

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

6.1

307.7

1001

947

N05CD02

ATC

nitrazepam; oral

34.0

307.7

1715

295

F34.1

ICD-10 Finland

Dysthymia

4.0

307.7

3037

4515

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.5

307.7

3109

7401

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

4.0

307.7

5286

8063

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

4.3

307.7

1895

2584

P18

ICPC

Medication abuse

10.0

307.7

662

380

C08CA01

ATC

amlodipine; oral

1.5

307.7

22020

94659

A02BC05

ATC

esomeprazole; systemic

1.8

307.7

27476

104739

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

307.7

9755

23246

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.7

307.7

2313

3634

G04CA02

ATC

tamsulosin; oral

1.6

307.7

13352

52157

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

307.7

17009

65691

N05AX12

ATC

aripiprazole; systemic

4.6

307.7

3905

5102

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

21.5

307.7

448

120

N02BE01

ATC

paracetamol; systemic, rectal

2.0

307.7

59285

301171

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

19.0

307.7

537

163

N05AA02

ATC

levomepromazine; systemic

10.9

307.7

5039

2841

R53

ICD-10 Finland

Malaise and fatigue

1.7

307.7

16591

62042

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

307.7

10860

41193

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

5.9

307.7

886

869

N06AB10

ATC

escitalopram; oral

3.0

307.7

18320

42687

G47.3

ICD-10 Finland

Sleep apnoea

1.5

307.7

14050

57480

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

307.7

30206

126479

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.9

307.7

2918

4466

J01MA12

ATC

levofloxacin; systemic

1.7

307.7

11126

39886

N06AX18

ATC

reboxetine; oral

5.8

307.7

844

841

N05AH03

ATC

olanzapine; systemic

5.3

307.7

6840

8090

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.2

307.7

6501

9479

N03AX12

ATC

[U] gabapentin; oral

2.4

307.7

11807

31065

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

307.7

30544

117878

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

307.7

6904

23765

N07BB01

ATC

disulfiram; oral

5.3

307.7

4546

5205

F51.0

ICD-10 Finland

Nonorganic insomnia

4.5

307.7

18738

30377

N03AF01

ATC

carbamazepine; oral, rectal

2.7

307.7

3225

7063

T36

ICD-10 Finland

Poisoning by systemic antibiotics

6.4

307.7

4742

4527

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

307.7

5775

18137

R03AC02

ATC

salbutamol; inhalant

1.5

307.7

35205

159206

UKC02

NOMESCO Finland

Cystoscopy

1.6

307.7

8922

32715

Z2445

NOMESCO Finland

Psychologist

2.5

307.7

2419

5547

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.4

307.7

1396

2352

N06AX26

ATC

vortioxetine; oral

2.9

307.7

6391

13306

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.7

307.7

8161

18846

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

307.7

4001

11427

F32

ICD-10 Finland

Depressive episode

2.5

307.7

3851

9176

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

307.7

10787

35707

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

15.7

307.7

486

178

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

307.7

8062

29024

J01DB01

ATC

cefalexin; oral

1.6

307.7

53657

273149

J01AA02

ATC

doxycycline; systemic

1.7

307.7

50650

245887

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

307.7

17502

67495

A28

ICPC

Limited function/disability NOS

1.8

307.7

10040

34263

Z3226

NOMESCO Finland

Physiotherapist

1.7

307.7

10821

37952

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

4.3

307.7

1231

1640

C01DA14

ATC

isosorbide mononitrate; oral

1.7

307.7

7918

28144

N05AH04

ATC

quetiapine; oral

5.9

307.7

21682

28691

N05AH02

ATC

clozapine; systemic

4.7

307.7

1504

1864

P76

ICPC

Depressive disorder

2.9

307.7

5362

11125

N05AD03

ATC

melperone; systemic

6.9

307.7

1003

835

P29

ICPC

Psychological sympt/compl other

2.5

307.7

5438

13254

R06AE07

ATC

cetirizine; oral

1.5

307.7

27101

120678

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

6.9

307.7

1704

1435

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.0

307.7

4907

5942

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

6.3

307.7

788

718

L28

ICPC

Limited function/disability (L)

1.7

307.7

10871

39538

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.6

307.7

828

860

L03

ICPC

Low back symptom/complaint

1.5

307.7

17698

74372

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.4

307.7

2053

3475

N03AG01

ATC

valproic acid; systemic, rectal

4.2

307.7

5713

8261

N06AG02

ATC

moclobemide; oral

4.8

307.7

3735

4684

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

307.7

23942

97881

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

307.7

8119

29085

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.7

307.7

3612

3217

P72

ICPC

Schizophrenia

4.2

307.7

1433

1964

SPAT1240

SPAT

Therapeutic discussion

2.1

307.7

6846

19419

N06AA04

ATC

clomipramine; systemic

4.8

307.7

1233

1488

N06AA12

ATC

doxepin; systemic

7.7

307.7

5287

4197

F31.8

ICD-10 Finland

Other bipolar affective disorders

5.8

307.7

1771

1769

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.8

307.7

2659

4143

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

5.4

307.7

1194

1293

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.8

307.7

2182

4555

N05AN01

ATC

lithium; oral

6.8

307.7

2489

2166

N06AB03

ATC

fluoxetine; oral

4.0

307.7

11540

18671

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

307.7

10146

35059

P03

ICPC

Feeling depressed

2.2

307.7

6954

19077

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

307.7

17806

58342

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.9

307.7

1223

1797

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.5

307.7

1629

2090

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

307.7

5870

19260

N05CD05

ATC

triazolam; oral, sublingual

24.0

307.7

1084

262

M01AH05

ATC

etoricoxib; oral

1.4

307.7

39204

189008

N06AX05

ATC

trazodone; oral

9.9

307.7

2859

1707

C07AB07

ATC

bisoprolol; oral

1.8

307.7

31145

123416

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.5

307.7

3370

7832

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.6

307.7

2420

3908

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.7

307.7

2443

3923

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

307.7

21149

91931

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.9

307.7

1316

1112

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

307.7

11637

45151

M79.6

ICD-10 Finland

Pain in limb

1.5

307.7

27852

122674

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.7

307.7

1537

1910

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

307.7

19528

76627

M01AX17

ATC

nimesulide; oral

1.6

307.7

13412

51607

N05BA01

ATC

diazepam; systemic, rectal

5.4

307.7

14063

17761

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.7

307.7

1554

1932

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.4

307.7

7395

18837

N06AX21

ATC

duloxetine; oral

3.2

307.7

10560

21075

M48.0

ICD-10 Finland

Spinal stenosis

1.8

307.7

6809

22446

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.7

307.7

2008

2494

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

307.7

15973

60640

A06AD11

ATC

lactulose; oral

2.5

307.7

10097

25723

F10.24

ICD-10 Finland

Alcohol depence active use

5.5

307.7

1366

1443

A02BC03

ATC

lansoprazole; oral

1.9

307.7

18707

65313

N06AB08

ATC

fluvoxamine; oral

5.4

307.7

2259

2441

N03AX16

ATC

[U] pregabalin

2.6

307.7

18079

47100

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

307.7

13736

55512

L17

ICPC

Foot/toe symptom/complaint

1.5

307.7

18196

77541

M03BX02

ATC

tizanidine; oral

1.6

307.7

40975

187006

A01

ICPC

Pain general/multiple sites

2.0

307.7

6349

19097

P99

ICPC

Psychological disorders other

3.9

307.7

2596

3867

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.6

307.7

2190

3515

N05AF05

ATC

zuclopenthixol; systemic

6.9

307.7

840

702

R03BB04

ATC

tiotropium bromide; inhalant

2.0

307.7

5996

17742

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

17.4

307.7

485

160

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

307.7

5699

16756

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.9

307.7

19360

66966

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

307.7

11302

43952

P15

ICPC

Chronic alcohol abuse

4.0

307.7

2648

3883

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

307.7

11246

42870

A02BA02

ATC

ranitidine; systemic

2.1

307.7

12363

37453

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.5

307.7

3598

8559

C10AA01

ATC

simvastatin; oral

1.5

307.7

22659

97038

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.7

307.7

8555

14490

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

6.3

307.7

732

665

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

307.7

21526

95344

P74

ICPC

Anxiety disorder/anxiety state

2.9

307.7

3236

6684

E0000UV, ,

ATC

1.4

307.7

25200

114086

J01FA06

ATC

roxithromycin; oral

1.5

307.7

23725

104073

N05BA04

ATC

oxazepam; oral

4.8

307.7

27872

49533

C07AA05

ATC

propranolol; systemic

2.6

307.7

16334

41683

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

307.7

14570

49415

A02BA04

ATC

nizatidine; systemic

2.0

307.7

4130

11960

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.4

307.7

2742

2550

C07AB02

ATC

metoprolol; systemic

1.7

307.7

11192

40368

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

7.4

307.7

909

713

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.7

307.7

1419

1076

N02AA05

ATC

oxycodone; systemic

2.0

307.7

11611

35946

B18.2

ICD-10 Finland

Chronic viral hepatitis C

5.5

307.7

949

994

P01AB01

ATC

metronidazole; oral, rectal

1.5

307.7

24818

106283

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

4.6

307.7

2070

2632

M01AE02

ATC

naproxen; oral, rectal

1.5

307.7

35140

163387

R06.0

ICD-10 Finland

Dyspnoea

1.7

307.7

17100

63650

N06AB05

ATC

paroxetine; oral

3.9

307.7

5323

8281

M54.5

ICD-10 Finland

Low back pain

1.6

307.7

23583

99003

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

6.9

307.7

1406

1180

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

5.0

307.7

1220

1428

R42

ICD-10 Finland

Dizziness and giddiness

1.5

307.7

13463

54160

F61.0

ICD-10 Finland

Mixed personality disorders

6.0

307.7

1608

1567

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

6.3

307.7

761

699

N05AB03

ATC

perphenazine; systemic, rectal

5.4

307.7

3193

3493

A04

ICPC

Weakness/tiredness general

1.6

307.7

9400

34544

N03AX09

ATC

lamotrigine; oral

4.7

307.7

4912

6334

UJF32

NOMESCO Finland

Coloscopy

1.6

307.7

15504

60967

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

3.8

307.7

1970

3019

J01EA01

ATC

trimethoprim; systemic

1.5

307.7

14457

58893

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

307.7

23233

91903

N05CD07

ATC

temazepam; oral

21.6

307.7

17151

5982

N06AB06

ATC

sertraline; oral

3.6

307.7

10651

19008

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.8

307.7

950

806

J01DA01

ATC

[U] cefalexin

1.5

307.7

38368

183049

N05AL01

ATC

sulpiride; systemic

7.0

307.7

1195

990

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.1

307.7

2480

4726

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

307.7

4890

14292

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

307.7

19953

77486

A03CA02

ATC

clidinium and psycholeptics; oral

2.7

307.7

3490

7510

H02AB06

ATC

prednisolone; systemic

1.6

307.7

30751

131335

V03AA01, ,

ATC

7.1

307.7

1422

1172

J01FF01

ATC

clindamycin; systemic

1.5

307.7

16404

66874

N05CD08

ATC

midazolam; nasal, systemic

15.5

307.7

2388

911

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.9

307.7

1847

2763

N05AF03

ATC

chlorprothixene; systemic

9.2

307.7

3020

1943

ZY010

NOMESCO Finland

Hospital outpatient

2.6

307.7

3553

7949

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

307.7

6378

20772

N05BA12

ATC

alprazolam; oral

4.4

307.7

9590

13882

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

307.7

11138

42815

N05AB01

ATC

dixyrazine; systemic

11.1

307.7

1159

608

M01AC06

ATC

meloxicam; systemic, rectal

1.5

307.7

21047

90178

N02AX02

ATC

tramadol; systemic, rectal

2.2

307.7

31798

111019

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

307.7

14184

53774

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

307.7

18964

68242

P01

ICPC

Feeling anxious/nervous/tense

2.0

307.7

8322

25489

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.4

307.7

1627

2130

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.6

307.7

2583

5828

F31

ICD-10 Finland

Bipolar affective disorder

6.1

307.7

1150

1096

N05AF01

ATC

flupentixol; systemic

6.0

307.7

1191

1149

Z2221

NOMESCO Finland

Medical doctor

1.5

307.7

15966

66821

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.8

307.7

1826

2814

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

307.7

11599

45357

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

6.1

307.7

1018

958

N06AX12

ATC

bupropion; oral

3.3

307.7

6597

12380

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

307.7

6490

21212

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.3

307.7

3652

9184

Z71.8

ICD-10 Finland

Other specified counselling

1.4

307.7

20841

91830

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

8.7

307.7

620

412

J02AC01

ATC

fluconazole; systemic

1.5

307.7

24013

103198

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

6.8

307.7

1276

1088

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

6.5

307.7

1875

1686

N06AA06

ATC

trimipramine; systemic

10.1

307.7

2479

1451

N06AB04

ATC

citalopram; systemic

4.0

307.7

20360

37795

M02AA07

ATC

piroxicam; topical

1.5

307.7

20810

86868

N05CF02

ATC

zolpidem; oral

17.5

307.7

29396

16248

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.7

307.7

1535

2390

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

307.7

25344

109399

S18

ICPC

Laceration/cut

1.4

307.7

27923

129660

Z2446

NOMESCO Finland

Social worker

2.6

307.7

4386

10016

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

307.7

36528

169294

N04BC05

ATC

pramipexole; oral

2.6

307.7

5039

11460

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

6.1

307.7

1783

1720

P06

ICPC

Sleep disturbance

2.9

307.7

11089

24722

R52.2

ICD-10 Finland

Other chronic pain

2.5

307.7

2372

5433

P16

ICPC

Acute alcohol abuse

4.3

307.7

1314

1758

C03CA01

ATC

furosemide; systemic

1.9

307.7

18472

64781

N06AX16

ATC

venlafaxine; oral

3.9

307.7

14421

24974

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.5

307.7

1001

1298

N05AX08

ATC

risperidone; systemic

3.2

307.7

6795

13102

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.8

307.7

1946

4014

N05BA06

ATC

lorazepam; systemic, sublingual

4.9

307.7

4600

5700

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

307.7

24690

112315

M01AH02

ATC

rofecoxib; oral

1.8

307.7

6853

23287

N05BE01

ATC

buspirone; oral

7.1

307.7

3074

2558

A02BC01

ATC

omeprazole; systemic

1.9

307.7

17981

62322

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

307.7

15074

61157

N05AD01

ATC

haloperidol; systemic

4.0

307.7

2386

3523

F32.1

ICD-10 Finland

Moderate depressive episode

2.3

307.7

4083

10443

M01AG02

ATC

tolfenamic acid; oral, rectal

1.6

307.7

8563

31320

AA1AD

NOMESCO Finland

CT of head and brain

1.8

307.7

18353

66403

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

307.7

13384

51793

N04AA02

ATC

biperiden; systemic

6.3

307.7

1697

1577

N02BF02

ATC

pregabalin; oral

2.7

307.7

5139

11404

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

7.0

307.7

698

577

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

307.7

17309

73631

S06.0

ICD-10 Finland

Concussion

1.8

307.7

6534

21759

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.3

307.7

4133

5748

N03AE01

ATC

clonazepam; systemic

4.3

307.7

5077

7094

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

307.7

7181

16404

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

307.7

20946

87993

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.3

306.7

1377

2388

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

306.3

21997

98956

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

5.1

304.7

812

923

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

10.0

303.6

474

272

F39

ICD-10 Finland

Unspecified mood [affective] disorder

3.5

302.4

1268

2098

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

302.1

3385

9415

C10AA05

ATC

atorvastatin; oral

1.4

299.8

23585

107642

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

9.7

299.5

477

283

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.7

299.2

1938

4188

R11

ICD-10 Finland

Nausea and vomiting

1.8

298.7

5073

16344

N05BA05

ATC

potassium clorazepate; oral

6.8

298.0

605

509

WX002

NOMESCO Finland

Sedation and analgesia

1.5

298.0

10435

40776

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

297.9

15499

65718

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

17.4

297.4

358

118

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.7

296.3

1903

4094

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

293.4

27986

131640

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

8.4

292.8

511

350

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.8

292.7

1758

3645

N05AE04

ATC

ziprasidone; systemic

7.2

292.4

572

459

H02AB04

ATC

methylprednisolone; systemic

1.6

292.1

8161

30223

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

292.0

11195

44602

A10BA02

ATC

metformin; oral

1.4

290.4

15842

67716

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.7

289.7

1831

3904

G04BD12

ATC

mirabegron; oral

1.7

289.7

6421

22375

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

288.9

44724

226669

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

3.9

287.8

1028

1510

A03FA02

ATC

cisapride; oral, rectal

2.0

287.7

3920

11724

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

287.3

8479

31813

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

285.7

7397

26860

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

284.9

33755

163925

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

284.1

2946

7939

N06AA10

ATC

nortriptyline; systemic

3.2

281.9

1347

2433

ZXE00

NOMESCO Finland

One hour or less

1.4

281.0

22331

101789

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.2

279.7

2827

7537

ZXA00

NOMESCO Finland

Right side

1.5

279.2

13983

58742

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

6.7

278.6

573

490

R01AD09

ATC

mometasone; nasal

1.4

278.5

27307

128640

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

278.1

7172

26004

K59.0

ICD-10 Finland

Constipation

2.1

278.0

3221

9070

R35

ICD-10 Finland

Polyuria

1.9

277.4

3959

12031

C03DA01

ATC

spironolactone; oral

1.7

276.6

6684

23825

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

276.0

4780

15479

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

275.2

4951

16222

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

275.0

5461

18429

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

274.2

6272

22027

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

273.8

2560

6602

M25.5

ICD-10 Finland

Pain in joint

1.4

273.0

19640

87955

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

272.6

8845

33902

A01AB09

ATC

miconazole; local oral

1.8

272.0

4531

14490

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

7.3

271.5

524

413

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

16.5

271.0

333

116

W78

ICPC

Pregnancy

0.5

270.7

2466

28347

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

270.7

7128

25971

G44.2

ICD-10 Finland

Tension-type headache

1.6

270.6

7982

29909

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

270.6

7255

26554

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

6.0

270.0

616

595

A07AA02

ATC

nystatin; oral

2.1

269.6

3150

8896

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

7.9

269.3

488

353

ZY000

NOMESCO Finland

Hospital inpatient

4.1

268.5

896

1246

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

7.2

267.8

522

417

V03AB30, ,

ATC

7.3

267.4

514

403

A29

ICPC

General symptom/complaint other

1.6

266.9

7615

28299

F99

ICD-10 Finland

Mental disorder, not otherwise specified

3.1

265.7

1331

2477

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

7.8

265.7

487

358

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

265.4

10418

41617

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

265.2

4884

16109

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

265.1

2666

7090

F33

ICD-10 Finland

Recurrent depressive disorder

2.8

264.7

1558

3192

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

7.3

263.9

509

401

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

263.8

5695

19671

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

263.3

22178

101755

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

262.7

5513

18891

N07BA03

ATC

varenicline; oral

2.1

261.9

3040

8562

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

261.4

7127

26179

A07DA03

ATC

loperamide; oral

2.5

260.1

1895

4349

D11

ICPC

Diarrhoea

1.6

258.7

7104

26136

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

258.7

7524

28075

SPAT1301

SPAT

No procedures

1.4

258.0

17240

76095

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

5.2

257.7

665

732

Z72.2

ICD-10 Finland

Drug use

7.5

256.9

486

373

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

256.6

16635

73033

R50.9

ICD-10 Finland

Fever, unspecified

1.5

255.7

8797

34124

C05AA08

ATC

fluocortolone; rectal, topical

1.6

255.3

7515

28115

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.6

255.1

5102

46628

G04BD08

ATC

solifenacin; oral

2.0

253.9

3394

10071

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.3

252.9

2327

5956

D07AC01

ATC

betamethasone; topical

1.4

252.7

21270

97409

P19

ICPC

Drug abuse

4.7

251.7

722

880

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

251.2

23040

106904

SPAT1197

SPAT

Extensive health check-up of expecting family

0.5

250.0

1955

23757

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

249.8

5764

20261

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.5

249.7

530

471

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

249.6

11338

46595

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

6.3

249.1

541

494

ZXA05

NOMESCO Finland

Left side

1.4

248.6

12910

54427

G04BD07

ATC

tolterodine; oral

2.2

248.5

2417

6335

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

248.5

10923

44592

M01AB55

ATC

diclofenac, combinations; oral

2.0

246.8

3378

10105

SPAT1234

SPAT

Support of social functional capacity

2.1

246.2

2731

7553

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

4.0

245.8

847

1209

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

244.9

14702

63600

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

7.3

244.4

469

367

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

243.4

4767

15998

M02AA10

ATC

ketoprofen; topical

1.5

243.3

8686

33936

T90

ICPC

Diabetes non-insulin dependent

1.4

243.0

13287

56514

Z72.1

ICD-10 Finland

Alcohol use

3.9

242.9

884

1317

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.6

240.5

6354

54493

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

240.4

3602

11113

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

4.4

238.7

738

962

B01AA03

ATC

warfarin; systemic

1.5

238.6

9441

37690

IGY02, ,

SPAT

3.3

238.3

1100

1942

R52.9

ICD-10 Finland

Pain, unspecified

1.6

236.6

6050

21833

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.2

235.4

2333

6162

D12

ICPC

Constipation

2.3

234.8

2128

5408

R03BA01

ATC

beclometasone; inhalant

1.6

233.4

7648

29294

SPAT1216

SPAT

Assessment of functional ability

1.5

233.2

7793

29980

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.4

232.8

1977

4880

ZXD05

NOMESCO Finland

Urgent procedure

1.4

232.6

17208

76976

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

232.3

24591

116162

N06AA22, ,

ATC

7.2

232.0

451

359

J01MA14

ATC

moxifloxacin; systemic

1.7

232.0

4923

16895

M04AA01

ATC

allopurinol; systemic

1.6

231.4

6733

25080

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

230.7

7091

26757

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

9.7

230.2

365

215

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

230.2

5837

21010

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

229.7

13912

60167

R33

ICD-10 Finland

Retention of urine

1.8

229.3

4215

13871

OAB43, ,

SPAT

0.7

229.3

12800

95331

U02

ICPC

Urinary frequency/urgency

1.5

228.9

7956

30868

205

Kela drug reimbursment

Chronic hypertension

1.4

228.5

13378

57507

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.6

227.3

1612

3648

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.1

225.9

2618

7361

M79.7

ICD-10 Finland

Fibromyalgia

2.3

225.5

2047

5205

F40.1

ICD-10 Finland

Social phobias

2.7

225.5

1454

3131

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

225.3

11252

46978

M01AX05

ATC

glucosamine; oral

1.5

225.1

9044

36177

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

8.6

224.7

384

255

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

221.8

14810

65054

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

221.3

7331

28123

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

219.7

14617

64150

WX892

NOMESCO Finland

Monitored bed care

1.8

218.7

4117

13639

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

4.9

218.7

602

706

R01AD08

ATC

fluticasone; nasal

1.4

218.2

16340

73091

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

218.1

3121

9472

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.4

218.0

1795

4367

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

217.6

6736

25437

R07.3

ICD-10 Finland

Other chest pain

1.6

215.1

5759

20998

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

214.9

15509

68935

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

214.8

3983

13134

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

214.7

13028

56262

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

214.4

44472

229288

F41.00

ICD-10 Finland

Moderate panic disorder

3.2

214.3

1001

1781

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.1

213.3

1058

1956

J01MA06

ATC

norfloxacin; oral

1.6

213.2

6758

25650

R03BA05

ATC

fluticasone; inhalant

1.5

213.1

10031

41362

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

212.8

13375

58092

SPAT1379

SPAT

Health check-up of pregnant person

0.4

212.0

1537

19264

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.6

212.0

5230

18672

XKD00

NOMESCO Finland

Uroflowmetry

1.5

211.4

8101

32053

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

211.3

11429

48350

A02BX02

ATC

sucralfate; oral

2.2

211.0

2008

5210

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.4

210.8

647

838

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

210.6

16674

75154

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

209.8

10502

43795

F61

ICD-10 Finland

Mixed and other personality disorders

7.2

209.8

408

325

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

4.7

209.7

598

725

EBA00

NOMESCO Finland

Extraction of tooth

1.3

209.5

20922

97601

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

5.0

209.3

568

657

R03DC03

ATC

montelukast; oral

1.5

209.2

9177

37313

R03BA02

ATC

budesonide; inhalant

1.4

208.5

9867

40711

D01

ICPC

Abdominal pain/cramps general

1.5

208.2

6819

26066

SFA30

NOMESCO Finland

Three-surface restoration

1.3

208.0

24820

118663

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

207.2

7160

27696

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

207.0

12231

52531

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

206.9

3757

12306

A06AC51

ATC

ispaghula, combinations; oral

2.0

205.6

2579

7466

SPAT1380

SPAT

Postpartum check-up

0.4

205.5

1171

16142

SPAT1265

SPAT

Breathalyser

4.2

204.9

670

916

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

204.9

4035

13538

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

204.5

57659

309894

Z39.2

ICD-10 Finland

Routine postpartum follow-up

0.5

204.3

2366

25284

W19

ICD-10 Finland

Unspecified fall

1.6

203.9

5472

19948

S01.0

ICD-10 Finland

Open wound of scalp

1.7

203.3

4319

14806

F32.8

ICD-10 Finland

Other depressive episodes

3.1

202.8

1008

1866

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.0

202.6

2739

8145

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

3.1

202.6

1039

1961

SPAT1260

SPAT

Consultation of another employee

1.5

202.5

9317

38212

IGV01

NOMESCO Finland

Psychiatric network contact

4.0

202.4

695

989

J05AB01

ATC

aciclovir; systemic

1.4

202.3

12107

52085

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

201.7

17147

78027

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

201.0

3529

11439

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

200.9

5210

18828

L13

ICPC

Hip symptom/complaint

1.4

200.8

10220

42714

SPAT1243

SPAT

Psychiatric/psychological examination

2.5

200.6

1485

3432

N30.0

ICD-10 Finland

Acute cystitis

1.5

200.5

9231

37859

M01AB01

ATC

indometacin; systemic, rectal

1.8

200.4

3699

12174

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

199.9

5967

22314

E66.8

ICD-10 Finland

Other obesity

1.8

199.8

3308

10527

J01CA04

ATC

amoxicillin; systemic

1.3

199.0

51041

269328

G04CA01

ATC

alfuzosin; oral

1.6

198.8

6414

24418

R05

ICPC

Cough

1.4

197.6

14036

62086

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.7

197.5

4553

15956

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.0

197.1

2640

7824

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

197.1

15107

67624

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

7.1

197.1

389

316

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

197.0

4002

13542

N03AF02

ATC

oxcarbazepine; oral

2.2

196.8

1868

4840

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

12.9

196.6

268

119

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

196.0

8340

33668

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

195.7

13485

59344

R13

ICD-10 Finland

Dysphagia

1.8

194.9

3703

12288

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

194.8

9568

39702

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

194.5

4612

16281

K08.3

ICD-10 Finland

Retained dental root

1.7

194.0

4358

15162

SPAT1252

SPAT

Overall medication plan or its review

1.8

193.8

3367

10876

S29

ICPC

Skin symptom/complaint other

1.4

193.2

11327

48505

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

193.2

3517

11523

U07

ICPC

Urine symptom/complaint other

1.7

193.2

4527

15930

R60.0

ICD-10 Finland

Localized oedema

1.5

192.6

6706

25955

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

6.1

192.4

426

398

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.5

191.5

7373

29153

A02BA03

ATC

famotidine; systemic

2.2

190.7

1882

4957

L08

ICPC

Shoulder symptom/complaint

1.4

189.9

12898

56587

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

189.5

1461

3444

F22.0

ICD-10 Finland

Delusional disorder

3.3

189.0

867

1524

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

10.1

188.5

293

167

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

188.4

7463

29676

JN4BD

NOMESCO Finland

Extensive body CT

1.6

188.3

5146

18827

N06BA04

ATC

methylphenidate; oral

2.2

188.2

1865

4920

R41.0

ICD-10 Finland

Disorientation, unspecified

2.3

188.1

1608

3978

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

188.0

2277

6504

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

3.1

187.9

936

1735

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.3

187.3

1666

4195

N05AE05

ATC

lurasidone; oral

7.1

187.3

369

299

N05AX15

ATC

cariprazine; oral

6.8

186.6

381

323

D07AA02

ATC

hydrocortisone; topical

1.5

186.6

7499

29901

N05AC01

ATC

periciazine; systemic

8.0

186.6

336

241

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

186.2

17411

80147

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

185.6

3063

9733

C09CA06

ATC

candesartan; oral

1.4

185.2

13546

60097

N05BB01

ATC

hydroxyzine; systemic

1.8

185.2

3165

10167

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

184.9

5497

20518

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

4.3

184.6

591

794

J01FA09

ATC

clarithromycin; systemic

1.3

184.3

17277

79533

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

14.1

184.0

241

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

183.9

3918

13429

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

0.6

183.8

2952

28756

R55

ICD-10 Finland

Syncope and collapse

1.6

183.7

5838

22127

E000001, ,

ATC

1.4

183.3

10584

45155

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

7.8

183.0

335

246

A11

ICPC

Chest pain NOS

1.6

180.7

4513

16136

2961D

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,VAIKEA-ASTEINEN]

8.0

180.6

325

233

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

180.0

5422

20293

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

180.0

3734

12701

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

4.4

179.6

557

728

K30

ICD-10 Finland

Functional dyspepsia

1.5

179.5

6266

24242

A46

ICD-10 Finland

Erysipelas

1.5

179.3

7910

32112

X61

ICD-10 Finland

Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified

8.9

178.9

299

192

R03AC03

ATC

terbutaline; inhalant

1.5

178.3

7345

29414

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

17.9

178.0

212

J01CA08

ATC

pivmecillinam; oral

1.3

177.1

21536

102585

R06AX22

ATC

ebastine; oral

1.4

176.6

9448

39745

F20

ICD-10 Finland

Schizophrenia

5.1

176.0

460

513

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.8

175.8

3217

10548

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.8

175.6

3013

9688

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

10.2

175.3

271

153

G03FA01

ATC

norethisterone and estrogen; systemic

1.5

175.3

5949

22869

IHZ05, ,

SPAT

1.9

174.6

2382

7100

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

174.6

1808

4856

IHZ04, ,

SPAT

2.7

174.6

1076

2260

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

5.6

174.2

419

429

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

174.0

4219

14965

F60.8

ICD-10 Finland

Other specific personality disorders

4.8

173.8

487

581

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.0

173.5

2158

6223

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

173.2

3840

13299

M01AC01

ATC

piroxicam; systemic, rectal

1.5

173.0

6589

25955

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

172.4

1186

2641

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

0.5

172.2

2283

23489

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

172.0

13061

58179

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

4.7

172.0

491

596

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

0.6

171.9

3131

29544

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

0.6

171.2

3037

28851

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

171.1

22110

106016

A01AB04

ATC

amphotericin B; local oral

2.0

170.7

2209

6462

M79.1

ICD-10 Finland

Myalgia

1.4

170.6

8284

34219

A97

ICPC

No disease

1.4

170.3

10935

47425

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

170.1

5846

22527

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

169.9

12093

53317

A04AA01

ATC

ondansetron; systemic, rectal

1.6

168.0

4318

15540

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

167.9

6566

25996

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

167.6

6440

25406

F25.21

ICD-10 Finland

Schizoaffective syndrome, mixed type with prolonged schizophrenic than bipolar symptoms

8.4

167.0

291

199

SPAT1229

SPAT

Assessment of need for aid

1.7

166.9

3628

12494

A02BC04

ATC

rabeprazole; oral

1.6

166.1

4666

17162

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

5.1

166.1

442

502

SPAT1263

SPAT

Sampling

1.3

165.7

23161

112024

Z00.0

ICD-10 Finland

General medical examination

1.4

165.4

10386

44852

C09CA01

ATC

losartan; oral

1.3

165.4

13394

60193

P80

ICPC

Personality disorder

5.8

165.2

382

375

-1, ,

NOMESCO Finland

1.3

164.9

18189

85344

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

164.9

12608

56169

SFA10

NOMESCO Finland

One-surface restoration

1.3

164.5

32551

164033

R96

ICPC

Asthma

1.6

164.4

5179

19566

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

163.7

4058

14468

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

163.5

5612

21608

F20.0

ICD-10 Finland

Paranoid schizophrenia

4.7

163.3

473

582

C09AA05

ATC

ramipril; oral

1.3

163.2

12455

55461

F05.9

ICD-10 Finland

Delirium, unspecified

2.6

163.0

1130

2526

XF402

NOMESCO Finland

ECG with work load test

1.6

162.3

5060

19067

ZX120

NOMESCO Finland

Intravenous

1.6

162.3

4774

17749

R5110, ,

SPAT

1.6

162.3

4341

15774

T74.1

ICD-10 Finland

Physical abuse

2.6

162.1

1114

2479

J01MA01

ATC

ofloxacin; systemic

1.6

162.0

4094

14666

G72.8

ICD-10 Finland

Other specified myopathies

2.9

162.0

881

1723

L86

ICPC

Back syndrome with radiating pain

1.7

161.7

3335

11315

C09AA02

ATC

enalapril; systemic

1.4

161.6

9526

40690

IEY01

NOMESCO Finland

Psychoeducation, individual

4.2

160.4

528

726

MAX99

NOMESCO Finland

Assistance to normal delivery

0.5

160.1

1458

16904

B01AC04

ATC

clopidogrel; oral

1.4

159.2

7885

32656

L15

ICPC

Knee symptom/complaint

1.3

159.1

13566

61372

X58

ICD-10 Finland

Exposure to other specified factors

1.4

158.9

8322

34813

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

158.9

1693

4599

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

158.1

7113

28932

G04CB01

ATC

finasteride; oral

1.5

157.6

5295

20285

P20

ICPC

Memory disturbance

1.5

157.4

6395

25496

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

157.0

6800

27455

N05AA03

ATC

promazine; systemic

22.5

156.7

173

G03FB05

ATC

norethisterone and estrogen; systemic

1.6

156.4

4557

16897

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

156.4

6023

23749

C08DA01

ATC

verapamil; systemic

2.0

155.6

2031

5957

309

Kela drug reimbursment

Nalmefene and naltrexone

6.1

155.6

347

327

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.1

155.5

1758

4888

A12BA01

ATC

potassium chloride; oral

2.0

155.3

1848

5239

K92.0

ICD-10 Finland

Haematemesis

2.4

154.3

1262

3058

SPAT1262

SPAT

Handing over of treatment supplies

1.4

154.2

8805

37378

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

154.1

1810

5106

L01

ICPC

Neck symptom/complaint

1.4

153.7

8912

37928

C03AA03

ATC

hydrochlorothiazide; oral

1.6

153.5

4161

15161

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

153.5

4832

18239

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

153.4

12487

56067

KMAK, ,

NOMESCO Finland

1.2

153.2

29780

149271

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

152.9

6143

24428

R06AX27

ATC

desloratadine; oral

1.3

152.8

16162

75257

E87.6

ICD-10 Finland

Hypokalaemia

2.1

152.5

1780

5009

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

8.9

152.4

255

164

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.8

152.3

2460

7754

OAA80, ,

SPAT

0.6

152.3

2806

26449

R01AD01

ATC

beclometasone; nasal

1.4

152.3

8027

33597

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

151.9

5244

20201

R03DA04

ATC

theophylline; systemic, rectal

1.8

151.6

2431

7644

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.9

151.3

2077

6201

-50

ICPC

Medication/prescr/renewal

2.0

151.2

1992

5861

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.6

150.8

1050

2352

SPAT1097

SPAT

Recording of ECG

1.4

150.1

7031

28796

C08CA13

ATC

lercanidipine; oral

1.4

150.1

7170

29474

WX402

NOMESCO Finland

General anaesthesia

1.3

149.9

12496

56272

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

5.9

149.8

344

335

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.8

149.5

892

1840

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

149.3

2980

10012

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.0

149.3

1955

5740

N17

ICPC

Vertigo/dizziness

1.5

148.9

6520

26360

R4120

NOMESCO Finland

Occupational therapy

1.7

148.8

3444

12053

D07AC13

ATC

mometasone; topical

1.3

148.6

15756

73337

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

148.2

8014

33679

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

148.1

2739

9000

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

10.1

148.1

230

131

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

147.7

8396

35589

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

147.7

6551

26550

R05

ICD-10 Finland

Cough

1.3

147.6

11666

52112

K92.1

ICD-10 Finland

Melaena

1.8

147.5

2697

8831

R03BB01

ATC

ipratropium bromide; inhalant

2.0

147.4

1760

4995

JN4AD

NOMESCO Finland

Body CT examination

1.5

147.2

5879

23340

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.7

146.7

933

1993

U05

ICPC

Urination problems other

1.8

146.1

2632

8581

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

146.0

10806

47786

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.9

145.7

2081

6297

ICB06, ,

NOMESCO Finland

4.1

145.7

486

676

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

145.6

6279

25305

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

145.4

2936

9896

ZXA10

NOMESCO Finland

Bilateral

1.4

145.3

9158

39485

C07AG02

ATC

carvedilol; oral

1.8

145.1

2728

9007

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

144.9

3098

10609

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.3

144.9

1334

3409

S22.3

ICD-10 Finland

Fracture of rib

1.6

144.8

3827

13851

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

4.1

144.7

488

685

P28

ICPC

Limited function/disability (P)

3.9

144.6

526

784

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.2

144.4

1495

4013

N02AJ13

ATC

tramadol and paracetamol; systemic

2.3

144.4

1254

3123

R03AC12

ATC

salmeterol; inhalant

1.9

143.9

2173

6700

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

8271

30024

1.65

322.83

2.5

2.3

0.22

0.21

g/l

2.99

7673

28073

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

9857

37599

1.58

314.31

2.9

2.8

8.52

8.53

umol/l

0.02

8374

33044

(3020779) Urea [Moles/volume] in Serum or Plasma

7791

28103

1.66

310.65

8.2

7.8

9.63

9.82

mmol/l

1.29

7461

26886

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

57032

300866

1.52

309.39

6.5

5.1

1.85

1.88

mu/l

2.60

53500

281087

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

21350

89794

1.52

307.65

3.4

3.1

1403.94

1335.80

ng/l

1.14

18144

76815

(3044889) 12 lead EKG panel

45237

224444

1.45

307.65

4.6

3.8

5057.33

2065.67

0.25

440

(3036481) Cortisol [Moles/volume] in Serum or Plasma

8758

30174

1.76

307.65

2.4

2.3

369.13

378.51

nmol/l

3.89

8158

28164

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

27035

120327

1.47

307.65

4.4

3.5

52.01

67.97

ng/l

0.84

18836

79385

(3006504) Eosinophils/Leukocytes in Blood

34458

154117

1.56

307.65

7.7

6.4

2.79

2.86

5.28

32497

145160

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

49004

242068

1.56

307.65

5.0

4.2

12.42

11.36

mm/h

45.20

46055

227968

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

8432

30302

1.67

307.65

2.9

2.5

39.06

51.16

u/l

1.85

7180

25779

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

25476

102691

1.67

307.65

3.2

2.6

83.36

62.56

u/l

0.41

23641

95568

(3022096) Basophils/Leukocytes in Blood

34418

154163

1.56

307.65

7.8

6.5

0.68

2.01

32444

145040

(3012095) Magnesium [Moles/volume] in Serum or Plasma

14453

52437

1.73

307.65

3.9

3.5

0.81

0.82

mmol/l

12.48

13602

49498

(3037467) Urinalysis macro (dipstick) panel - Urine

45549

223224

1.50

307.65

5.4

4.3

2.00

44.66

0.53

327

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1106

1466

4.36

307.65

16.9

15.0

847.60

2368.79

nmol/l

0.77

1074

1417

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

15682

64777

1.50

307.65

1.8

1.7

40574408.75

33808093.85

pmol/l

0.61

13102

54603

(3001122) Ferritin [Mass/volume] in Serum or Plasma

34181

160793

1.43

307.65

3.6

3.1

128.10

121.15

ug/l

3.73

31977

151418

(3019977) pH of Arterial blood

9960

36024

1.68

307.65

8.3

8.0

7.41

7.42

2.47

5572

19274

(3030467) Casts [#/volume] in Urine by Automated count

21168

90288

1.49

307.65

3.8

3.2

0.41

e6/l

0.14

15888

65545

(3024666) Lithium [Moles/volume] in Serum or Plasma

1279

1276

5.82

307.65

14.0

13.0

0.62

mmol/l

0.06

1175

1183

(3018010) Neutrophils/Leukocytes in Blood

34439

155973

1.53

307.65

7.5

6.3

57.50

57.23

3.90

33025

149525

(3031040) Bacteria [#/volume] in Urine by Automated count

44309

211365

1.57

307.65

5.6

4.3

1902.71

1427.77

e6/l

0.80

672

2875

(3018418) pH of Serum or Plasma

23656

93643

1.68

307.65

5.0

4.2

7.40

2.01

17295

66093

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

34181

140693

1.78

307.65

7.9

6.5

1.21

mmol/l

1.84

31872

130708

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

10547

37541

1.72

307.65

2.1

1.8

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

9934

35992

1.68

307.65

8.3

8.0

5.12

5.08

kpa

4.95

9547

34652

(3014111) Lactate [Moles/volume] in Serum or Plasma

7952

28454

1.68

307.65

8.2

8.0

1.37

1.34

mmol/l

1.24

7774

27931

(3002030) Lymphocytes/Leukocytes in Blood

35102

158815

1.54

307.65

7.7

6.4

27.53

27.99

11.70

33429

151187

(3019198) Lymphocytes [#/volume] in Blood

37816

172164

1.58

307.65

7.6

6.3

1.91

1.92

e9/l

0.61

33516

152225

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

39155

169059

1.76

307.65

7.7

6.3

10.92

11.61

umol/l

17.38

37314

161173

(3024561) Albumin [Mass/volume] in Serum or Plasma

33993

142854

1.72

307.65

5.8

5.0

35.62

35.93

g/l

18.26

31947

134184

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

32487

139747

1.63

307.65

2.3

2.0

96.53

96.09

pmol/l

0.84

17605

76118

(3018095) Leukocytes [#/volume] in Urine

27093

121035

1.46

307.65

4.7

3.8

86.08

94.48

e6/l

0.74

19688

84371

(3023368) Bacteria identified in Blood by Culture

21937

86134

1.67

307.65

5.1

4.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

40652

187891

1.59

307.65

12.4

9.2

4.19

4.12

e9/l

6.65

35706

162989

(3013115) Eosinophils [#/volume] in Blood

38213

173757

1.59

307.65

8.0

6.4

0.19

e9/l

0.23

33655

152460

(3002582) Erythrocytes [#/volume] in Urine

24288

104812

1.50

307.65

4.0

3.3

73.85

84.38

e6/l

0.53

18889

79488

(36304419) Bacteria [Presence] in Urine

20245

85942

1.49

307.65

3.7

3.1

13.08

265.42

estimate

1.08

372

(3022948) Iron [Moles/volume] in Serum or Plasma

14160

55854

1.57

307.65

2.9

2.6

12.95

13.77

umol/l

1.56

13168

52291

(40768797) Stomach Pathology biopsy report

11286

43721

1.57

307.65

1.3

1.2

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

26374

108266

1.64

307.65

3.8

3.4

2.35

mmol/l

0.74

24166

99021

(3000850) Epithelial cells [#/volume] in Urine

17312

71445

1.52

307.65

3.1

2.7

5.78

5.36

e6/l

2.03

15828

65036

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

26522

115668

1.51

307.65

4.0

3.3

1.79

2.05

e6/l

0.24

(3019069) Monocytes/Leukocytes in Blood

34541

154522

1.56

307.65

7.8

6.5

8.79

0.00

32606

145641

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

15033

60894

1.53

307.65

3.1

2.9

2.45

2.44

mmol/l

3.65

13471

54549

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

9975

35309

1.72

307.65

2.1

1.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

50667

253442

1.56

307.65

5.2

4.3

14.67

14.69

pmol/l

1.51

47152

235060

(3006315) Basophils [#/volume] in Blood

37293

168607

1.59

307.65

7.5

6.3

0.04

e9/l

0.05

32430

145600

(3019309) Folate [Moles/volume] in Red Blood Cells

13831

49440

1.75

307.65

1.8

1.7

1163.14

1152.74

nmol/l

0.60

10616

37994

(3016502) Oxygen saturation in Arterial blood

8855

32113

1.66

307.65

8.6

8.4

95.39

95.73

4.78

8576

31004

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

52103

248341

1.86

307.65

10.2

7.9

79.71

78.37

u/l

6.84

49838

236497

(3033658) Prothrombin time (PT) actual/Normal

19384

82748

1.47

307.65

5.0

4.1

90.74

90.25

1.81

18890

80917

(3032080) INR in Blood by Coagulation assay

33448

145633

1.62

307.65

15.5

13.9

1.24

inr

0.70

28209

121231

(3001604) Monocytes [#/volume] in Blood

37209

168177

1.58

307.65

7.5

6.3

0.59

0.58

e9/l

21.37

32332

145316

(3009466) Valproate [Moles/volume] in Serum or Plasma

2494

3536

4.14

307.65

6.5

4.8

377.55

356.59

umol/l

7.44

2226

3079

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

12270

47638

1.58

307.65

2.9

2.6

22.22

23.06

8.43

11375

44390

(3021960) Folate [Moles/volume] in Serum or Plasma

22144

87332

1.67

307.65

1.8

1.7

20.51

19.79

nmol/l

9.52

19259

75004

(3027801) Oxygen [Partial pressure] in Arterial blood

9925

35978

1.67

307.65

8.3

8.0

12.01

12.69

kpa

28.99

9543

34628

(40758558) Short blood count panel - Blood

22326

97007

1.47

307.65

7.9

6.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

13307

51885

1.58

307.65

2.8

2.6

2.34

g/l

0.12

12232

48077

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

14805

60503

1.51

307.65

4.4

3.7

322.34

531.87

ng/l

5.81

11192

45456

(3013826) Glucose [Moles/volume] in Serum or Plasma

41156

190182

1.60

307.65

6.3

4.9

6.68

6.69

mmol/l

0.51

39343

179613

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

27059

110637

1.66

307.65

4.0

3.2

35.03

32.99

u/l

1.65

25571

104769

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

20738

83538

1.60

307.65

2.6

2.3

2.79

mg/l

0.03

18015

72436

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

37509

158208

1.79

307.65

8.7

7.1

1.21

mmol/l

3.53

32727

136870

(3003396) Base excess in Arterial blood by calculation

9859

35757

1.67

307.65

8.2

8.0

0.99

0.86

mmol/l

2.50

8240

29457

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6656

22153

1.79

307.65

1.8

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

11432

41368

1.70

307.65

6.8

6.2

1.04

mmol/l

0.71

10726

38620

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

32738

147135

1.52

307.65

2.7

2.4

77.53

684.67

nmol/l

0.50

30076

134784

(3026782) Osmolality of Urine

15105

60199

1.56

307.65

3.3

2.9

511.86

541.61

mosm/kgh2o

42.75

13315

52929

(3009508) Creatinine [Moles/volume] in Urine

24657

111674

1.41

307.65

3.8

3.5

7.44

7.83

mmol/l

28.24

20940

95481

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

12196

39768

1.92

307.65

2.3

1.7

1.56

1.42

59.02

10696

35397

(44816559) Phosphatidylethanol [Mass/volume] in Blood

5117

13000

2.35

307.65

2.0

1.7

0.32

0.31

mg/l

0.76

2749

6099

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

1166

1546

4.37

307.65

22.0

20.4

2294.53

2830.87

nmol/l

0.16

1128

1486

(3042936) Bacteria identified in Isolate by Culture

11644

45869

1.54

307.65

2.3

2.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

13764

51334

1.67

307.65

2.2

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

23886

97662

1.61

307.65

2.6

2.1

230.35

204.70

u/l

1.88

22639

92584

(3002173) Hemoglobin [Mass/volume] in Arterial blood

8199

30114

1.63

304.27

9.1

8.8

120.95

122.01

g/l

4.43

8020

29423

(3027945) Reticulocytes/Erythrocytes in Blood

9391

35684

1.58

303.29

2.7

2.6

1.83

1.74

11.84

8357

31976

(3015736) pH of Urine

29736

140962

1.36

298.77

3.9

3.3

6.24

6.19

10.61

16627

79618

(3035350) Ketones [Presence] in Urine by Test strip

36097

176900

1.35

289.03

4.4

3.7

5.00

4.07

estimate

0.43

7824

36465

(3009261) Glucose [Presence] in Urine by Test strip

36302

178123

1.35

287.79

4.5

3.7

0.20

0.26

estimate

0.14

7377

34476

(3021601) Nitrite [Presence] in Urine by Test strip

35717

174851

1.35

287.08

4.4

3.6

0.00

estimate

0.54

7672

35803

(3021447) Carbon dioxide [Partial pressure] in Venous blood

8401

31664

1.59

278.62

4.7

3.9

5.85

5.80

kpa

4.08

8157

30947

(4198724) Urine methamphetamine measurement

848

1108

4.41

273.53

2.4

—

(3002032) Base excess in Venous blood by calculation

8186

30791

1.59

273.38

4.8

4.0

1.74

1.73

mmol/l

0.08

7202

27067

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

45067

229552

1.36

272.35

4.4

3.1

55.30

45.71

u/l

63.02

42538

217654

(3023183) Ammonium ion [Moles/volume] in Plasma

2487

6368

2.28

270.31

2.9

2.7

33.91

33.74

umol/l

0.10

2261

5759

(3012544) pH of Venous blood

8447

32128

1.57

268.75

4.7

4.0

7.37

7.38

2.47

4938

18370

(3021589) Normoblasts [#/volume] in Blood

30558

147272

1.34

262.35

13.9

11.0

0.00

e9/l

0.14

24969

120162

(3019550) Sodium [Moles/volume] in Serum or Plasma

60775

327394

1.58

260.75

25.2

16.8

139.43

139.72

mmol/l

145.57

59880

321162

(3018677) aPTT in Platelet poor plasma by Coagulation assay

11813

48649

1.47

258.41

2.3

2.1

29.68

29.62

0.51

11459

47412

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

5334

18279

1.72

253.68

4.8

4.2

24.22

24.17

mmol/l

0.50

5233

18081

(3023103) Potassium [Moles/volume] in Serum or Plasma

60839

328139

1.57

253.39

25.4

16.9

3.97

mmol/l

5.36

59877

321324

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

16639

73210

1.40

252.66

1.9

1.8

1.18

1.20

mg/l

0.25

12876

56688

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

12410

51863

1.45

250.64

3.5

3.0

2.95

2.74

e6/l

1.06

6162

24951

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

705

848

4.79

249.30

2.6

149.35

146.92

nmol/l

0.17

615

763

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

824

1145

4.15

247.11

2.3

1.8

123.94

138.15

umol/l

0.47

405

553

(3013512) EKG study

22896

106570

1.34

241.92

4.0

3.5

0.67

0.76

0.71

249

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

13303

56741

1.42

238.99

3.4

2.9

1.29

1.08

e6/l

0.45

7102

29891

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

9255

36859

1.50

236.40

4.5

236.49

243.51

u/l

4.52

8770

35091

(3023520) Reticulocytes [#/volume] in Blood

7232

27274

1.58

236.23

2.7

2.6

71.30

68.90

e9/l

5.74

5241

20012

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5856

21039

1.65

232.78

8.6

24.85

24.70

mmol/l

2.13

5817

20882

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3534

10957

1.89

232.18

2.3

547.79

556.70

ug/l

0.04

3343

10347

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

5301

18564

1.68

232.12

9.9

10.2

24.25

24.24

mmol/l

0.10

5170

18156

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

5762

20669

1.65

230.30

4.1

3.7

5.15

5.12

kpa

1.75

5518

19712

(3009343) pH of Capillary blood

5586

20098

1.64

220.15

4.1

3.7

7.41

7.42

4.46

4745

16645

(3024354) Oxygen [Partial pressure] in Venous blood

6946

26388

1.56

218.66

3.9

3.3

4.70

4.56

kpa

5.26

6704

25732

(3020682) Albumin/Creatinine [Ratio] in Urine

22438

105272

1.32

218.22

4.3

4.2

9.85

8.42

mg/mmol

3.30

13949

66407

(3042517) Benzodiazepines panel - Urine

358

227

9.05

215.81

3.2

2.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

31435

154790

1.30

213.24

3.1

2.7

—

estimate

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1208

2426

2.88

212.33

1.8

1.4

1.39

1.25

promille

2.04

959

1933

(3020630) Protein [Mass/volume] in Serum or Plasma

6724

25593

1.56

209.32

2.9

2.6

66.10

66.54

g/l

4.57

6160

23598

(3012516) Albumin [Mass/volume] in Urine

22001

103386

1.32

209.15

3.6

53.10

48.98

mg/l

1.27

14003

66570

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4943

17495

1.66

206.92

4.0

3.6

1.72

1.67

mmol/l

0.40

3659

12764

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1394

17919

0.43

205.28

1.4

1.6

1035.90

1022.08

mu/l

0.16

1084

14836

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2994

9149

1.91

204.78

1.5

1.4

273.20

275.16

ug/g

0.16

1748

5259

(3007164) IgA [Mass/volume] in Serum or Plasma

15154

67535

1.36

204.71

1.6

1.5

2.43

2.39

g/l

1.32

9255

43222

(3048689) Calprotectin [Mass/mass] in Stool

10458

43874

1.43

201.30

2.4

2.5

140.50

126.75

ug/g

2.49

8358

35159

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

17060

77887

1.34

194.92

1.3

1.37

1.73

u/ml

3.66

4454

22098

(3026493) Urate [Moles/volume] in Serum or Plasma

18943

87848

1.32

194.05

3.0

2.6

343.83

340.20

umol/l

4.75

16622

78625

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

893

1588

3.24

191.29

2.2

2.1

—

(3003181) Sodium [Moles/volume] in Urine

1890

5016

2.19

188.02

1.5

1.4

59.43

63.33

mmol/l

3.33

1467

4004

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

6120

23363

1.55

186.72

4.3

4.1

93.20

89.96

ng/l

1.53

5361

20370

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

5530

20639

1.58

186.13

10.3

10.2

1.39

1.32

5.49

5502

20508

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

7647

30661

1.48

185.03

4.0

3.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4956

18048

1.61

184.62

10.1

10.2

16.00

16.18

4.25

4789

17415

(3022145) Colonoscopy Study observation

9076

37645

1.44

184.14

1.4

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

5379

20004

1.58

183.68

10.6

10.5

0.63

0.64

1.37

5353

19891

(3014007) Fractional oxyhemoglobin in Arterial blood

5530

20705

1.57

183.47

10.5

10.3

93.64

94.05

4.69

5507

20648

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

59799

324661

1.44

183.13

22.0

14.6

23.95

23.99

mg/l

0.11

51914

265035

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

6041

23125

1.54

181.77

3.1

2.9

198.33

196.84

ng/l

0.08

5527

21075

(3000494) Fungus identified in Specimen by Culture

9436

39513

1.42

181.46

1.6

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

17374

80468

1.31

175.76

2.7

2.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

17072

79024

1.31

172.82

4.2

3.6

0.26

0.28

0.10

136

715

(3008152) Bicarbonate [Moles/volume] in Arterial blood

5093

19048

1.57

169.09

7.7

6.8

24.68

24.45

mmol/l

3.96

4886

18227

(3005719) IgG [Mass/volume] in Serum or Plasma

6450

25523

1.49

165.22

3.0

2.8

10.38

10.64

g/l

4.09

5943

23669

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

56422

304417

1.35

163.38

7.2

6.0

39.21

38.99

mmol/mol

6.62

53094

287220

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

5498

21091

1.53

162.88

3.4

3.6

4.39

4.54

pmol/l

22.81

4862

19191

(3037522) Nuclear Ab [Titer] in Serum

11003

48193

1.36

159.92

1.4

466.90

532.14

titre

3.19

2186

10031

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

57151

309179

1.35

159.65

5.9

4.8

5.99

5.89

mmol/l

57.98

53027

287629

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3951

14260

1.62

151.43

1.8

1.7

1.56

1.52

g/l

2.25

3422

12245

(3015235) Bicarbonate [Moles/volume] in Capillary blood

3177

10861

1.70

149.66

3.1

2.8

24.63

24.62

mmol/l

0.04

3119

10671

(3019150) Specific gravity of Urine by Refractometry

16467

77145

1.29

147.60

4.6

3.8

1.11

1.12

kg/l

0.04

11295

50438

(3017143) Hepatitis C virus Ab [Presence] in Serum

9354

40447

1.37

145.82

1.8

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2688

8859

1.76

143.81

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

7098

29519

1.42

138.57

2.8

2.3

13.11

13.00

nmol/l

0.48

6317

26966

(3029937) Albumin [Presence] in Urine by Test strip

19851

95760

1.26

138.30

4.7

3.9

0.00

estimate

0.57

7168

32964

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

6045

24439

1.45

137.41

4.6

3.8

1.22

1.23

mmol/l

2.26

5244

21154

(3025941) Bacteria identified in Stool by Culture

4673

17953

1.52

136.36

1.3

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

6052

24535

1.45

135.48

1.5

—

(3050129) First trimester maternal screen panel - Serum or Plasma

921

11880

0.44

135.27

1.4

1.5

—

(3017181) Myelocytes/Leukocytes in Blood

7001

29244

1.41

132.92

4.9

4.4

0.99

0.94

0.67

2351

8446

(3028026) IgM [Mass/volume] in Serum or Plasma

5035

19804

1.49

131.17

2.0

1.9

1.26

1.31

g/l

0.98

4627

18317

(3002179) Metamyelocytes/Leukocytes in Blood

6660

27834

1.41

125.58

4.6

4.2

0.73

0.71

0.31

2212

8078

(21494755) Public health laboratory ask at order entry panel

4635

37533

0.68

122.96

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1893

5872

1.87

122.86

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1892

5872

1.86

122.59

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

884

2017

2.52

122.45

1.8

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

19717

96111

1.24

121.33

3.2

2.8

0.12

0.06

1.49

336

2055

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

7418

31752

1.38

121.08

4.2

4.3

21.75

27.33

ug/l

0.82

6100

25409

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2611

8987

1.69

119.45

1.4

1.3

—

(3017732) Neutrophils [#/volume] in Blood

9427

41973

1.33

118.87

3.8

3.0

4.56

4.51

e9/l

0.22

8131

36653

(3025159) Blasts/Leukocytes in Blood

6704

28341

1.39

117.72

5.2

4.6

0.14

0.34

2.66

1906

7016

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2398

8097

1.72

117.57

1.7

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

2343

7866

1.73

117.23

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

614

8804

0.39

116.98

1.5

1.6

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

57068

311395

1.30

116.18

20.5

14.1

81.89

83.14

ml/min/173m2

38.06

53724

286430

(3021440) Promyelocytes/Leukocytes in Blood

6635

28061

1.39

116.12

4.9

4.4

0.12

0.06

1987

7308

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6026

25072

1.41

115.98

2.5

2.3

6.87

7.70

ug/l

1.76

5237

22153

(3024928) Oxygen saturation in Venous blood

2331

7839

1.72

115.92

3.6

3.4

62.38

62.47

0.07

2211

7592

(1616796) Gas panel - Central venous blood

2131

6984

1.77

115.84

4.0

3.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

2361

7992

1.71

114.70

3.7

3.6

8.25

8.35

kpa

2.13

2303

7803

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3332

12370

1.57

112.60

2.7

2.2

4.23

4.21

g/l

0.39

3046

11352

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3334

12389

1.56

112.20

2.7

2.2

7.31

7.35

g/l

0.59

3047

11355

(3010421) pH of Blood

2737

9695

1.64

112.16

4.1

3.5

7.41

0.55

2701

9554

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3177

11676

1.58

112.08

2.7

2.3

2.87

2.89

g/l

0.30

2890

10645

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3324

12353

1.56

111.81

2.7

2.2

3.67

3.74

g/l

1.76

3042

11330

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

3294

12220

1.57

111.64

2.1

1.9

2.22

2.20

ug/l

0.03

2942

10845

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2889

10389

1.61

111.49

2.6

—

(3008295) Osmolality of Serum or Plasma

1140

3047

2.16

111.21

1.5

279.12

279.47

mosm/kgh2o

0.16

844

2369

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

26514

134114

1.21

111.15

4.4

3.6

0.72

0.39

estimate

0.81

6339

29627

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

4225

16590

1.48

110.20

3.7

3.0

1.37

1.25

7.24

4204

16517

(3004119) Hemoglobin [Mass/volume] in Venous blood

4852

19596

1.45

109.61

3.9

3.3

128.45

130.13

g/l

5.39

4718

19080

(3019225) pH of Specimen

6778

29025

1.37

109.54

4.9

4.0

7.36

0.84

5116

20782

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2918

10614

1.60

107.39

2.8

2.4

0.75

0.78

g/l

0.21

2502

9182

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

826

10166

0.46

106.53

1.4

1.5

61.67

62.16

ug/l

0.07

651

8332

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

13483

63742

1.26

105.74

1.4

1.3

36.15

33.56

iu/ml

0.26

3968

19522

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

4171

16477

1.48

105.42

3.7

3.0

0.62

0.90

4154

16428

(3021901) Oxygen saturation in Capillary blood

1966

6485

1.75

104.45

3.1

3.0

90.16

90.30

0.43

1912

6317

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

713

1597

2.57

102.52

1.9

1.4

2511611.72

1574333.89

iu/ml

1.01

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

27023

137798

1.20

100.37

2.0

1.9

1.47

1.35

mmol/l

65.62

22757

117269

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

795

9684

0.46

99.54

1.3

1.5

1.22

1.19

ratio

0.42

449

5823

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

795

9683

0.46

99.51

1.3

1.5

0.96

0.95

ratio

0.31

447

5776

(3047181) Lactate [Moles/volume] in Blood

2566

9215

1.61

99.37

6.2

5.5

1.35

1.31

mmol/l

0.99

2266

8170

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

12443

58641

1.26

99.26

1.3

9.51

10.86

u/ml

1.18

4632

23845

(42529406) Shigella sp [Presence] in Stool by Culture

2396

8465

1.64

99.01

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2977

11087

1.56

98.95

4.5

3.9

24.76

mmol/l

0.01

2773

10233

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

782

9560

0.46

98.89

1.3

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

794

9650

0.46

98.78

1.3

1.5

1.16

ratio

0.02

446

5744

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2882

10658

1.57

98.75

2.6

2.3

9.90

10.25

g/l

3.76

2559

9534

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2377

8398

1.64

98.20

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2387

8449

1.64

97.90

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1879

6234

1.74

97.81

1.7

1.6

—

(3013290) Carbon dioxide [Partial pressure] in Blood

1905

6348

1.73

97.66

4.3

3.8

5.03

4.98

kpa

1.66

1866

6197

(3012501) Base excess in Blood by calculation

1904

6347

1.73

97.48

4.3

3.8

2.48

2.45

mmol/l

0.16

1324

4229

(3027315) Oxygen [Partial pressure] in Blood

1913

6388

1.73

97.35

4.3

3.9

8.63

8.68

kpa

0.55

1874

6236

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2425

8652

1.62

96.36

2.6

2.3

0.00

g/l

0.01

2092

7631

(40767503) Oxygen content in Capillary blood by calculation

1917

6444

1.72

95.29

2.9

2.6

16.42

16.68

2.83

1881

6301

(3045414) Leukocytes [Presence] in Urine

6983

30683

1.33

94.50

2.2

2.0

0.02

0.03

estimate

0.52

1458

6349

(3052851) Hemolysis interference index of Serum or Plasma

2402

8591

1.62

94.49

3.5

3.1

2.28

2.18

index

0.23

1337

4267

(3030981) Hyaline casts [#/volume] in Urine by Automated count

6146

26543

1.35

93.15

2.8

2.4

0.40

e6/l

0.01

5912

25315

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2502

9085

1.59

92.51

2.6

2.3

0.04

0.02

g/l

0.46

2230

8213

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

425

6429

0.37

91.44

1.4

1.5

58.56

59.99

ug/l

0.29

425

6429

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2746

10221

1.56

91.36

4.0

3.2

47.01

41.87

mg/l

0.51

2333

8675

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3562

14032

1.47

90.88

5.7

4.7

1.73

1.63

5.92

3368

13331

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

250

294

4.87

90.84

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

2745

10236

1.55

90.58

4.0

3.2

68.53

60.59

mg/l

0.19

2334

8686

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2691

9992

1.56

90.47

3.3

3.2

0.34

0.35

iu/ml

1.28

1455

5460

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2390

8634

1.60

90.23

2.1

1.9

201.02

201.77

pmol/l

0.12

2256

8245

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

2061

7198

1.66

88.94

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

6192

26959

1.34

88.75

1.2

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1358

4208

1.86

88.30

6.2

11.53

11.58

mg/l

0.13

1256

3915

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1977

6868

1.66

87.05

5.9

6.0

2866.70

1170.32

iu/ml

0.34

278

1017

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

4020

16366

1.43

86.21

1.1

1.53

10.16

u/ml

2.22

199

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2251

8116

1.60

85.61

2.6

2.4

0.00

g/l

-0.00

2086

7618

(3028271) Lactate [Moles/volume] in Capillary blood

1451

4661

1.80

84.15

2.1

1.8

1.72

1.74

mmol/l

0.39

1418

4531

(3043238) Trisomy 21 risk [Likelihood] in Fetus

675

8211

0.46

84.05

1.4

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

2612

9810

1.54

83.39

4.5

4.1

1.41

1.38

mmol/l

0.57

2558

9627

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3471

13836

1.46

83.19

1.5

1.6

15.41

13.81

iu/ml

0.17

373

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2450

9081

1.56

82.90

3.9

3.1

4.63

3.85

ratio

0.29

1420

5155

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2972

11525

1.49

81.73

2.1

1.8

40.40

41.15

nmol/l

0.87

2891

11309

(3047352) Trisomy 18 risk [Likelihood] in Fetus

661

8021

0.47

81.73

1.4

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1651

5555

1.71

81.73

1.1

—

(3005033) Fetal Nuchal fold Thickness US

650

7921

0.46

81.33

1.4

1.5

1.26

0.02

442

5700

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2116

7618

1.61

80.92

2.4

2.2

129.86

131.23

g/l

1.51

1615

5896

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2434

9118

1.54

78.54

1.9

1.7

—

(3020891) Body temperature

3586

14572

1.43

77.44

5.4

4.5

36.93

36.90

°c

2.85

3545

14448

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

5822

42522

0.76

76.93

2.1

1.9

3.46

3.52

ratio

2.28

4530

32434

(3007930) Methemoglobin/Hemoglobin.total in Blood

3212

12801

1.45

76.92

6.0

5.0

0.88

0.03

3028

12129

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

7761

35551

1.28

76.03

8.1

6.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

20494

103825

1.18

74.93

5.7

5.2

2.69

3.25

ug/l

2.32

18386

94677

(3007566) Smooth muscle Ab [Titer] in Serum

2502

9527

1.52

74.91

1.2

1.3

114.94

120.52

titre

0.10

257

906

(3041096) Erythrocytes [Presence] in Urine by Automated

19231

96941

1.19

74.42

3.8

3.1

0.26

0.23

estimate

0.13

6208

28711

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1712

5977

1.65

73.90

1.5

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1564

5340

1.69

73.40

2.8

3.0

10738.96

4855.24

u/ml

0.34

299

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2996

11893

1.46

73.16

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1554

5311

1.69

72.67

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1616

5583

1.67

72.59

1.1

—

(3039000) Anion gap in Blood by calculation

1757

6219

1.63

71.88

7.3

6.6

11.22

11.32

mmol/l

0.63

1595

5612

(3018572) Chloride [Moles/volume] in Blood

1757

6220

1.63

71.84

7.3

6.6

104.81

105.17

mmol/l

2.12

1595

5615

(3037756) Immunofixation for Serum or Plasma

1735

6140

1.63

71.03

1.9

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

1283

4198

1.76

69.98

1.5

1.6

28.57

33.73

ng/l

1.44

1275

4191

(3023419) Bacteria identified in Sputum by Culture

1188

3806

1.80

69.52

2.6

2.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

6066

27224

1.30

69.16

1.6

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

2428

9360

1.50

68.52

1.2

733.64

956.37

titre

0.90

270

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1812

6544

1.60

68.34

1.5

—

(3016038) Potassium [Moles/volume] in Urine

693

1847

2.15

68.21

1.2

31.86

35.06

mmol/l

2.87

596

1639

(40760888) Immunoglobulin light chains.free panel - Serum

1843

6696

1.59

67.80

4.1

3.2

856.39

0.90

—

(3045424) Erythrocytes [Presence] in Urine

3736

15679

1.38

66.77

2.2

2.1

0.22

0.09

estimate

0.26

1188

4956

(3019230) Fractional oxyhemoglobin in Venous blood

1860

6799

1.58

66.69

3.7

3.1

61.81

62.96

1.33

1850

6776

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

4257

31850

0.75

66.24

1.8

1.6

3.40

3.51

mmol/l

7.11

2980

21584

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1382

4695

1.70

66.06

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2227

8509

1.51

65.53

1.3

1.4

521.73

550.39

mg/l

0.81

2132

8177

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1992

7440

1.55

65.03

1.4

28.56

33.56

e6/l

0.24

1490

5508

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1687

6064

1.60

64.86

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

1222

4031

1.74

64.84

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

1222

4032

1.74

64.79

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

1222

4035

1.74

64.62

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

1222

4038

1.74

64.46

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

2008

7538

1.54

64.07

1.4

1.5

1626.13

2126.29

e6/l

0.29

1601

5927

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1861

6925

1.55

61.75

1.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

352

4877

0.41

61.62

1.2

—

(3007463) Buprenorphine [Presence] in Urine

115

7.47

61.23

9.3

7.4

—

(4035726) Immunohistochemistry procedure

6056

27645

1.28

60.00

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

2149

8303

1.49

59.92

4.9

4.5

3.86

3.89

mmol/l

1.48

2133

8229

(3009214) Lutropin [Units/volume] in Serum or Plasma

2639

10623

1.44

59.69

1.4

9.85

10.06

u/l

0.31

2078

8627

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2322

9167

1.46

58.15

1.5

15.74

13.69

iu/ml

0.22

205

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3683

15786

1.35

57.45

4.8

3.9

50.06

47.46

7.82

3622

15577

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1669

14306

0.66

57.43

1.1

0.64

0.63

ratio

0.39

256

1658

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1149

3859

1.71

57.27

1.6

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

3062

12760

1.39

56.89

1.7

343.49

291.52

mu/l

7.24

2767

11604

(3022806) Fractional oxyhemoglobin in Capillary blood

1079

3572

1.74

56.59

2.0

1.8

89.23

90.04

3.77

1064

3518

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1973

7581

1.50

56.48

1.3

3.81

3.73

mmol/l

2.02

1859

7201

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2732

11183

1.41

56.30

3.5

3.6

1808.91

1971.59

u/ml

0.05

2366

9675

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

50171

275025

1.16

55.69

27.0

17.7

13.75

13.55

196.95

49670

271467

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1173

4007

1.68

54.99

1.6

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1314

4635

1.63

54.50

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

3332

14176

1.36

54.45

4.2

3.4

25.28

25.22

mmol/l

0.46

3221

13707

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2785

11509

1.40

54.32

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3150

13313

1.37

53.65

1.3

0.90

0.81

u/ml

0.15

247

1049

(3020564) Creatinine [Moles/volume] in Serum or Plasma

61857

345663

1.25

53.27

27.6

18.6

78.67

76.93

umol/l

23.79

61284

341903

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3023

12709

1.38

53.19

1.6

15.46

16.90

u/ml

0.47

602

3292

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2488

10133

1.42

52.71

3.5

3.6

1.58

1.50

mg/l

4.52

2296

9329

(4024509) Urine culture

3250

13857

1.36

52.34

2.1

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4412

19692

1.30

51.73

1.4

27.10

26.84

iu/l

0.20

3713

16987

(3040151) Glucose [Moles/volume] in Capillary blood

1040

3504

1.71

51.29

14.8

5.2

7.43

7.34

mmol/l

0.18

879

2883

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3348

14400

1.34

50.91

2.0

2.1

39.28

39.74

u/l

0.61

2968

12964

(3004809) Band form neutrophils/Leukocytes in Blood

1405

5126

1.58

50.79

3.3

3.4

1.51

1.55

0.14

1271

4598

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2534

10427

1.40

50.62

1.8

1.7

0.23

0.24

g/l

0.49

2421

9957

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

5228

23943

1.27

49.97

2.4

22.65

20.41

au/ml

1.08

554

2819

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2589

10727

1.39

49.68

1.8

1.7

1.19

g/l

0.29

2482

10281

(40761536) Microorganisms panel - Urine sediment

5652

26190

1.25

48.85

4.7

3.7

—

(3037121) Protein [Mass/volume] in Urine

2567

10689

1.39

47.80

3.5

3.3

597.54

480.46

mg/l

0.45

1249

5020

(3013139) Helicobacter pylori Ag [Presence] in Stool

5021

23006

1.27

47.71

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2671

11204

1.38

47.58

2.0

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

803

2566

1.80

47.52

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

61439

343575

1.23

47.13

15.6

11.3

27.47

26.59

u/l

11.77

60033

334762

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2878

12260

1.36

46.53

2.2

2.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4828

22125

1.27

45.74

1.3

45.37

52.32

au/ml

1.47

293

1400

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1131

4031

1.61

45.07

1.5

1.4

—

(40768443) Skin Pathology biopsy report

3380

14815

1.32

45.06

1.3

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1109

3935

1.62

45.00

1.5

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

100

6.02

44.85

1.6

1.4

514.13

509.00

nmol/l

0.02

100

(3005322) IgE [Units/volume] in Serum or Plasma

4958

22886

1.26

44.10

1.4

1.3

237.84

236.50

u/ml

0.02

4611

21421

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1062

3750

1.63

43.94

1.5

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1034

3628

1.64

43.87

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

821

2707

1.74

43.77

3.0

2.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1106

3950

1.61

43.73

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1058

3737

1.63

43.73

1.5

1.4

—

(3002256) Pathology report gross observation

9080

44595

1.19

43.59

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1059

3746

1.62

43.52

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

939

3223

1.67

43.34

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1965

15534

0.71

43.17

1.3

1.2

0.90

0.89

g/l

0.92

1951

15493

(3042631) Mycobacterium sp identified in Specimen

1099

3932

1.61

43.14

2.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

3283

14440

1.31

42.66

1.9

1.8

6.96

7.39

iu/ml

0.36

748

3423

(3036489) Thrombin time

2982

12956

1.33

42.23

2.2

2.1

20.95

21.08

0.43

2663

11382

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2106

8662

1.40

42.14

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

843

2837

1.71

41.84

3.7

3.8

—

(3045716) Anion gap in Serum or Plasma by calculation

945

3291

1.65

41.30

3.6

3.0

10.65

10.74

mmol/l

0.31

933

3249

(3023410) Appearance of Cerebral spinal fluid

957

3349

1.64

41.05

1.5

1.7

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

5594

26412

1.23

40.37

2.9

2.7

67.23

67.90

ml/min/173m2

0.55

2417

11002

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

919

3199

1.65

40.25

1.6

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

16068

82961

1.14

39.29

4.6

4.3

21.84

22.10

1.12

7229

39539

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2456

10484

1.35

39.12

2.8

2.7

3.60

g/l

0.01

2337

10072

(3013005) Retinol [Moles/volume] in Serum or Plasma

498

1455

1.96

38.77

1.7

1.9

2.00

1.94

umol/l

0.94

457

1333

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

704

2301

1.76

38.75

1.6

1.5

—

(3000012) Reticulocyte production index

1144

4248

1.55

38.40

2.3

2.2

0.92

0.91

0.22

806

2875

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

55053

305926

1.15

38.07

4.7

4.1

1.39

1.28

mmol/l

201.38

50834

285880

(40761511) CBC panel - Blood by Automated count

59965

335413

1.18

37.90

19.1

13.0

171.10

5.04

—

(3036180) Methadone [Presence] in Urine

9.18

37.42

3.7

2.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1457

5741

1.46

36.86

1.6

0.71

0.78

g/l

1.84

1133

4469

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

850

2970

1.64

36.74

1.8

1.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

5127

24215

1.23

36.73

1.2

110.53

147.22

u/ml

9.72

1783

9395

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

726

2436

1.71

36.49

1.2

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3854

17654

1.26

36.39

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1271

4902

1.49

35.80

1.8

1.7

—

(21494815) CD4 cells/Lymphocytes in Specimen

815

2840

1.65

35.61

2.2

39.04

38.85

0.13

798

2792

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

449

1306

1.97

35.46

2.7

2.4

54.87

51.40

umol/l

1.27

392

1142

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1080

4034

1.54

35.34

1.7

470.82

344.79

mu/l

3.57

851

3282

(46235355) HIV 1 and 2 tests - Meaningful Use set

12964

66395

1.14

35.12

2.1

2.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2158

9182

1.35

35.10

1.2

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

1082

4065

1.53

34.50

1.4

1.5

60.72

32.95

g/l

0.51

998

3673

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

194

2688

0.41

34.19

1.5

1.6

8.50

7.74

mmol/l

3.93

189

2578

(3023199) Leukocytes [#/volume] in Pleural fluid

976

3603

1.56

33.67

1.5

3948.88

3161.68

e6/l

0.30

706

2525

(3003129) Base excess in Capillary blood by calculation

997

3704

1.55

33.45

2.3

2.1

0.64

0.40

mmol/l

1.18

956

3536

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

580

1875

1.77

33.22

1.9

1.8

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1204

4679

1.48

32.71

1.3

0.15

0.28

nmol/l

2.78

102

276

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1377

5495

1.44

32.64

1.4

1.3

27.05

26.70

u/l

0.13

1086

4533

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1188

4609

1.48

32.55

1.3

1.00

1.53

nmol/l

0.41

1145

4459

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

736

2565

1.65

32.20

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

736

2565

1.65

32.20

1.7

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

736

2565

1.65

32.20

1.7

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2323

10125

1.32

32.13

2.6

196.00

187.98

3.69

2193

9653

(3035715) Granulocytes [#/volume] in Blood

1487

6036

1.42

32.11

3.5

3.3

4.18

4.10

e9/l

0.59

1480

6027

(3051651) Icteric interference index of Serum or Plasma

529

1685

1.80

31.84

4.1

3.7

0.79

0.91

index

1.48

522

1635

(3011648) Oxygen content in Venous blood

912

3361

1.56

31.73

2.3

2.7

10.90

11.08

0.59

906

3347

(3044242) Glucose [Moles/volume] in Arterial blood

504

1586

1.82

31.55

2.2

1.9

7.95

8.13

mmol/l

0.49

504

1586

(3017354) Segmented neutrophils/Leukocytes in Blood

900

3316

1.56

31.36

3.4

57.48

57.68

0.10

784

2854

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1039

3958

1.51

31.11

1.2

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

671

2304

1.67

31.09

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2486

10993

1.30

30.98

2.3

2.4

93.31

93.37

0.04

2389

10586

(3011985) Renin [Units/volume] in Plasma

1216

4799

1.46

30.58

1.6

74.68

63.17

mu/l

0.70

1064

4368

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1057

4059

1.50

30.47

2.2

1.8

3688.14

3929.27

titre

0.07

164

(3011412) CD3 cells [#/volume] in Blood

848

3106

1.57

30.33

2.4

1225.07

1214.64

e6/l

0.08

728

2733

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

451

1389

1.86

30.22

1.7

1.9

28.59

28.93

umol/l

0.29

430

1296

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2364

10427

1.31

30.02

1.3

40.62

37.41

u/ml

0.17

111

567

(3000475) Leukocytes [#/volume] in Synovial fluid

1877

8009

1.35

29.99

1.6

1.7

14572.70

13072.76

e6/l

0.62

1303

5754

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2106

9141

1.33

29.99

2.1

2.2

11.83

11.33

mg/l

1.46

1959

8630

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1331

5363

1.43

29.97

3.2

0.80

nmol/l

0.11

1034

4300

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1478

6070

1.40

29.89

1.3

1.2

210.40

110.86

titre

0.46

116

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1812

7695

1.35

29.86

1.2

40.13

44.42

u/ml

0.44

162

704

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1698

7139

1.37

29.82

1.3

38.05

46.08

u/ml

0.41

105

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

567

1881

1.73

29.79

1.4

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1310

5271

1.43

29.73

1.5

1.4

15.03

13.64

u/ml

0.16

109

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

558

1849

1.73

29.44

1.4

—

(4062490) Immunoglobulin typing, IgG

926

3484

1.53

29.41

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

938

3541

1.52

29.34

1.4

2.79

3.02

g/l

3.86

683

2543

(3017569) Oxygen content in Arterial blood

498

1599

1.78

29.25

2.3

2.2

15.95

16.03

0.16

498

1599

(3024139) IgG subclass 3 [Mass/volume] in Serum

936

3541

1.52

28.99

1.4

0.37

0.41

g/l

2.73

680

2548

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

9.89

28.91

3.5

2.6

2.79

2.11

ug/l

1.13

(3045788) Cell count panel - Pleural fluid

797

2911

1.57

28.88

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1599

6693

1.37

28.87

1.3

273.10

260.74

u/ml

0.97

1057

4283

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

340

966

2.02

28.77

1.1

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

936

3549

1.51

28.69

1.4

6.51

6.79

g/l

1.35

679

2549

(3028308) Erythrocytes [#/volume] in Pleural fluid

859

3197

1.54

28.67

1.5

64666.12

52579.49

e6/l

0.40

501

1809

(3004716) Salmonella sp identified in Stool by Organism specific culture

3418

15863

1.24

28.67

1.3

1.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1458

6026

1.39

28.43

1.3

1.2

253.89

295.73

titre

0.35

113

438

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1031

4004

1.48

28.17

2.2

32.72

32.47

1.03

1026

3977

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

58385

326994

1.14

28.10

6.4

5.5

2.65

2.75

mmol/l

139.68

54659

308038

(3017950) Salicylates [Moles/volume] in Serum or Plasma

6.81

27.96

1.8

1.2

1057.71

1790.67

umol/l

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

1211

4870

1.43

27.60

2.7

2.2

5.68

9.22

titre

0.73

133

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

416

1287

1.85

27.55

2.6

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

737

2673

1.58

27.54

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

627

2185

1.64

27.53

2.4

2.6

0.73

0.69

e9/l

0.53

592

2108

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2136

9404

1.31

27.50

2.1

2.0

12.51

12.59

iu/l

0.00

859

3887

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

883

3339

1.52

27.44

1.3

1.2

65.88

62.91

u/l

0.34

772

2954

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

1174

4705

1.43

27.27

4.3

3.6

32.34

38.72

u/ml

0.94

1134

4544

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

375

1132

1.90

26.78

2.9

0.60

0.61

mmol/l

1.00

375

1132

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

621

2175

1.64

26.76

1.4

12.38

12.98

u/l

1.37

598

2107

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1113

4433

1.44

26.73

1.4

431.95

344.95

pmol/l

0.44

953

3806

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1125

4495

1.44

26.57

2.7

2.8

1015.08

605.70

u/ml

0.21

1107

4448

(21494890) Protein electrophoresis panel - 24 hour Urine

829

3116

1.53

26.51

2.5

2.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

544

1845

1.69

26.48

1.7

1.5

20.98

23.52

umol/l

1.23

507

1712

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

207

2531

0.47

26.42

1.3

1.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1529

6462

1.36

26.03

3.6

3.5

636.82

1021.38

u/ml

0.91

1399

5827

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2193

9773

1.29

25.79

1.3

6.25

7.86

u/ml

0.75

288

1419

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

728

2681

1.56

25.53

1.8

2.4

17.75

18.48

nmol/l

1.40

672

2561

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

326

956

1.95

25.35

4.4

2.7

5.03

4.87

kpa

1.82

326

956

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

326

956

1.95

25.35

4.4

2.7

10.29

10.47

kpa

0.42

326

956

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

6.04

25.35

1.7

1.6

264.97

248.16

nmol/l

0.06

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1012

4003

1.45

25.24

1.3

0.23

0.26

nmol/l

0.23

787

3122

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1668

7180

1.34

25.19

1.5

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2188

9794

1.29

24.87

1.3

6.96

5.29

u/ml

0.30

178

924

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

743

2767

1.54

24.81

1.3

525.95

491.38

u/l

0.16

705

2617

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1650

7120

1.33

24.51

1.5

18.54

21.34

u/ml

0.34

139

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

120

223

3.08

24.49

1.3

1.2

52.02

44.87

mg/l

0.68

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

927

3634

1.46

24.24

2.3

2.0

24.16

25.84

mg/l

0.46

348

1359

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

913

3572

1.47

24.12

3.3

3.5

5.22

9.04

nmol/l

1.01

882

3462

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

966

3823

1.45

24.05

2.0

26.84

24.76

ug/l

0.34

944

3761

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

897

3501

1.47

23.99

1.2

43.75

31.04

nmol/l

—

(3010375) cycloSPORINE [Mass/volume] in Blood

415

1342

1.77

23.93

31.2

30.1

116.46

117.11

ug/l

0.07

343

1099

(3012920) Ethanol [Mass/volume] in Serum or Plasma

7.35

23.84

1.7

1.1

2.04

2.05

g/l

0.02

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1167

4788

1.40

23.83

1.1

1.53

1.50

g/l

1.55

1059

4407

(40768806) Pleura Pathology biopsy report

799

3052

1.50

23.76

1.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

348

1068

1.87

23.72

2.9

3.0

28.77

28.51

umol/l

0.14

250

829

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1308

5475

1.37

23.69

1.4

1.3

35.36

31.52

u/l

0.44

1132

4790

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

314

933

1.93

23.57

1.3

132.41

126.44

nmol/l

0.28

234

686

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

11927

62075

1.12

23.51

3.3

3.1

0.70

0.78

ug/l

13.60

7848

39052

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

7494

37908

1.15

23.35

5.2

4.7

31.93

32.10

0.64

5129

26325

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1366

5785

1.36

23.00

1.5

1.4

0.33

0.42

nmol/l

4.06

1029

4479

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

646

2374

1.56

22.93

2.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

57609

323059

1.12

22.88

5.6

4.9

4.57

4.66

mmol/l

90.50

54022

305634

(3022621) pH of Urine by Test strip

5354

26460

1.17

22.87

2.8

2.4

6.07

0.22

3543

17248

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

850

3315

1.47

22.85

1.5

1.2

17.05

56.06

u/ml

0.77

(1175426) CD3 cells/Lymphocytes in Blood

677

2517

1.54

22.83

2.1

74.20

72.56

2.12

642

2433

(3020876) Protein [Mass/time] in 24 hour Urine

981

3935

1.43

22.77

2.7

2.4

1.22

1.31

g/24h

0.48

596

2370

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

4.91

22.74

1.5

1.6

231.63

217.94

nmol/l

0.07

(3048929) Epstein Barr virus Ab [Presence] in Serum

2385

10914

1.26

22.64

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

527

1851

1.63

22.56

1.3

1.2

28.66

25.77

u/l

0.47

444

1570

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2680

12434

1.24

22.52

1.7

4.20

4.29

mg/l

0.16

2179

9107

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

515

1801

1.64

22.43

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

538

1903

1.62

22.40

1.3

1.2

96.64

94.52

u/l

0.15

456

1646

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

706

2668

1.52

22.12

1.2

132.94

207.19

titre

1.87

102

413

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

491

1704

1.65

22.04

1.6

1.4

—

(3036782) Glucose [Moles/volume] in Pleural fluid

768

2962

1.49

21.85

1.3

6.36

6.25

mmol/l

0.49

705

2767

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

7329

37175

1.14

21.84

2.3

2.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

703

2662

1.51

21.83

1.2

270.50

133.38

titre

0.71

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

649

2415

1.54

21.83

2.0

2.1

14.67

15.10

0.49

626

2356

(3010838) Calcium [Moles/time] in 24 hour Urine

1388

5941

1.34

21.83

1.9

2.0

4.88

5.28

mmol/24h

3.12

1233

5362

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

604

2212

1.56

21.79

2.4

2.5

520.72

536.21

e6/l

0.24

463

1791

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1791

7948

1.29

21.79

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

774

2992

1.48

21.77

3.9

3.3

14.95

13.44

index

2.32

523

1636

(3010015) Selenium [Moles/volume] in Serum or Plasma

148

332

2.55

21.71

1.9

1.29

1.34

umol/l

0.68

116

241

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

888

3529

1.44

21.69

1.1

14.31

77.35

au/ml

—

(3021788) Differential panel - Synovial fluid

1423

6122

1.33

21.63

1.5

1.00

0.96

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

453

1547

1.68

21.62

1.1

3.64

4.13

iu/ml

0.39

127

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

402

1331

1.73

21.45

1.4

—

(3044927) Protein electrophoresis panel - Urine

736

2826

1.49

21.41

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

402

1332

1.73

21.40

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

596

2186

1.56

21.38

1.2

1.3

14.71

14.40

u/l

0.08

547

2019

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

907

3629

1.43

21.37

1.1

34.22

26.55

au/ml

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

458

1574

1.67

21.36

1.6

1.7

15.92

5.07

nmol/l

0.46

380

1312

(40757494) Bilirubin.total [Moles/volume] in Blood

433

1466

1.69

21.34

2.1

2.2

27.56

36.48

umol/l

0.53

140

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

537

1924

1.60

21.26

1.5

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

335

1054

1.82

21.20

1.4

14.27

14.92

pmol/l

1.25

276

897

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

5.07

21.20

1.2

1.0

—

mmol/l

—

(3017704) Immunofixation for Urine

453

1561

1.66

20.92

1.9

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

820

3234

1.45

20.87

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1509

6582

1.32

20.86

1.5

152.34

148.62

au/ml

0.56

430

1907

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

701

2680

1.50

20.83

1.3

2.07

2.11

mmol/l

0.37

648

2496

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

7963

40727

1.13

20.81

2.4

2.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

467

1628

1.64

20.64

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

2018

9155

1.27

20.63

1.1

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

345

1108

1.78

20.45

1.4

1.5

673.29

702.31

mu/l

0.08

329

1057

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

349

1127

1.77

20.32

1.3

1.5

72.87

72.99

0.05

333

1076

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2407

11166

1.24

20.27

1.6

13.88

4.87

iu/ml

0.45

452

2020

(3020961) Endomysium IgA Ab [Titer] in Serum

3421

16444

1.20

20.20

1.1

183.57

190.73

titre

0.07

466

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

603

2248

1.54

20.16

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

609

2276

1.53

20.14

1.3

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1897

8568

1.27

20.12

1.3

12.03

17.93

u/ml

0.28

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1939

8785

1.27

20.05

1.4

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1825

8211

1.28

19.98

1.3

4.53

5.06

u/ml

0.14

108

553

(3019832) Treponema pallidum Ab [Presence] in Serum

5660

36699

0.87

19.96

1.9

1.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

500

1790

1.60

19.91

1.6

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

522

1889

1.58

19.87

2.8

39.44

39.18

0.09

260

1038

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

551

2020

1.56

19.85

2.0

2.2

99.74

98.37

0.38

516

1903

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

57240

321345

1.11

19.66

5.5

4.8

1.43

1.45

mmol/l

36.81

53415

302465

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

587

2193

1.53

19.46

1.5

24.92

25.77

u/ml

0.13

415

(3017315) Amylase [Enzymatic activity/volume] in Urine

472

1677

1.61

19.40

1.3

1.2

266.04

338.57

u/l

0.98

430

1577

(3026250) Tacrolimus [Mass/volume] in Blood

439

1537

1.64

19.13

42.4

43.2

7.11

7.36

ug/l

1.99

393

1406

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

823

3310

1.43

18.92

1.4

1.48

1.45

nmol/l

0.33

733

3007

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

462

1644

1.61

18.88

1.8

1.6

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

521

1911

1.56

18.76

1.3

590.57

512.54

titre

0.12

130

(3000034) Microalbumin [Mass/volume] in Urine

664

2567

1.48

18.76

3.0

49.60

56.28

mg/l

0.22

469

1848

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

717

2817

1.46

18.68

5.0

3.9

56.69

55.18

u/ml

0.04

708

2788

(3020911) Cortisol [Moles/time] in 24 hour Urine

345

1142

1.73

18.52

1.4

1.5

196.61

191.72

nmol/24h

0.02

345

1142

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

508

1860

1.56

18.45

1.3

73.06

78.19

titre

0.11

138

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

201

558

2.06

18.32

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

602

2296

1.50

18.18

2.6

226.41

234.39

e6/l

0.38

492

1952

(3010503) CD19 cells [#/volume] in Blood

516

1904

1.55

18.13

2.7

2.6

187.49

332.14

e6/l

1.05

498

1860

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

189

515

2.10

18.08

1.9

2.1

1.19

mmol/l

0.08

181

492

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

400

1393

1.64

17.84

4.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

680

2670

1.46

17.80

1.1

292.75

397.53

mg/l

0.47

618

2443

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

527

1970

1.53

17.49

1.1

4.94

5.71

nmol/l

0.13

377

(3014271) Vancomycin [Susceptibility]

372

1280

1.66

17.39

2.9

—

(3032057) Clostridioides difficile [Presence] in Stool

190

527

2.06

17.39

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

168

444

2.16

17.36

2.1

2.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1954

9020

1.24

17.25

1.2

3.67

3.81

0.31

257

1396

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

513

1918

1.53

17.03

1.1

1.15

1.12

u/l

0.22

203

794

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

571

2188

1.49

16.91

3.3

3.5

140.62

148.13

nmol/l

0.13

559

2155

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1959

9072

1.24

16.81

1.1

3.79

5.85

eliau/ml

1.63

212

1261

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

310

1027

1.73

16.66

1.1

—

(3047189) Immunofixation for 24 hour Urine

378

1322

1.64

16.63

2.1

1.7

—

(3004451) EKG impression Narrative

460

1694

1.55

16.36

1.3

—

(3017509) Phencyclidine [Presence] in Urine

138

346

2.28

16.17

2.1

1.7

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

628

2479

1.45

16.05

2.0

1.7

3.81

3.79

mg/l

0.04

600

2385

(3002079) Sodium [Moles/time] in 24 hour Urine

432

1578

1.57

15.94

1.2

1.3

155.98

161.97

mmol/24h

0.65

432

1578

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

914

3862

1.36

15.79

1.1

—

(40768446) Kidney Pathology biopsy report

384

1369

1.61

15.69

1.8

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

279

913

1.75

15.68

1.3

16.49

16.67

umol/l

0.23

245

785

(3034988) Calcium [Moles/volume] in Capillary blood

178

503

2.02

15.58

1.8

2.1

1.19

1.18

mmol/l

0.62

170

480

(3039162) Centromere protein B Ab [Units/volume] in Serum

996

4284

1.33

15.32

1.3

63.68

50.59

u/ml

0.69

242

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

428

1578

1.55

15.20

1.9

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

428

1578

1.55

15.20

1.9

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

428

1578

1.55

15.20

1.9

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

428

1580

1.55

15.11

1.9

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

680

2756

1.41

15.11

1.2

107.96

111.33

pmol/l

0.96

680

2756

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1102

4819

1.31

15.10

1.2

5.29

15.92

u/ml

3.14

200

(3045142) Bone marrow Pathology biopsy report

825

3458

1.37

15.03

1.4

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

323

1115

1.66

15.01

2.0

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

434

1611

1.54

14.96

1.3

59.20

63.96

0.45

197

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

323

1116

1.66

14.96

2.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

281

937

1.72

14.83

2.1

1.8

7257.94

13875.25

e6/l

1.07

159

453

(40768441) Liver Pathology biopsy report

606

2416

1.44

14.75

1.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

697

2850

1.40

14.74

1.2

1.1

38.39

44.18

mg/l

2.28

593

2414

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

504

1939

1.49

14.72

1.4

5.89

6.25

u/l

0.24

427

1669

(3023487) Leukocytes [#/volume] in Peritoneal fluid

317

1099

1.65

14.51

2.2

1.9

2176.15

3307.31

e6/l

0.26

212

721

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

324

1130

1.64

14.49

2.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

168

478

2.01

14.48

2.1

1.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

327

1147

1.63

14.31

2.4

1.9

39.98

40.47

g/l

0.69

327

1147

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1475

6747

1.25

14.19

2.1

2.3

0.92

0.86

nmol/l

1.91

1234

5776

(3028717) Thiamine [Mass/volume] in Blood

151

416

2.08

14.18

1.2

62.88

63.38

ug/l

0.11

151

416

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

673

2755

1.40

14.16

1.1

259.46

272.10

mg/l

0.74

602

2449

(43055514) Macroprolactin [Presence] in Serum or Plasma

255

840

1.74

14.08

1.3

1.4

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

540

2128

1.45

14.01

1.3

1.2

0.67

0.63

ratio

0.14

328

1211

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

636

2599

1.40

13.55

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

129

341

2.16

13.45

3.5

3.4

41.26

41.74

umol/l

0.08

113

288

(3002331) Protein [Mass/volume] in Peritoneal fluid

217

693

1.79

13.33

1.4

120.26

34.54

g/l

0.48

157

530

(21494434) Karyotype in Bone marrow

649

2670

1.39

13.31

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

957

4180

1.31

13.30

1.7

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

407

1532

1.52

13.25

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10720

56926

1.09

13.17

1.8

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

659

5116

0.73

13.11

1.5

1.4

2.74

3.43

ug/l

2.24

561

4541

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

406

1532

1.52

13.07

1.5

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

363

1338

1.55

13.00

3.1

3.3

1.42

1.30

0.49

363

1338

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

175

529

1.89

12.78

2.8

2.7

41.86

42.01

mg/l

0.00

119

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

493

1946

1.45

12.74

2.1

1.9

104.57

101.67

ng/l

0.23

493

1941

(3037692) Legionella sp identified in Specimen by Organism specific culture

292

1028

1.63

12.67

1.5

1.4

—

(3035880) pH of Pleural fluid

406

1544

1.50

12.63

1.3

7.40

0.18

281

1083

(3000093) Morphology [Interpretation] in Blood Narrative

722

3051

1.36

12.59

1.2

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

323

1168

1.58

12.57

1.3

1.2

0.53

0.42

g/l

0.14

(3041918) Cholesterol [Moles/volume] in Pleural fluid

176

537

1.87

12.51

1.3

1.2

1.44

1.67

mmol/l

1.91

114

340

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

450

1752

1.47

12.49

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

337

1233

1.56

12.48

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2206

10656

1.19

12.42

1.4

1.3

—

152.95

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

476

1876

1.45

12.41

1.7

1.5

6.62

7.11

u/l

0.32

372

1490

(40757373) Influenza virus identified in Isolate

172

523

1.88

12.36

1.7

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1389

6425

1.24

12.17

1.4

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

771

3309

1.33

12.16

1.2

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

146

422

1.98

12.15

2.7

2.4

2.58

2.43

0.13

146

414

(3036603) Volume of Urine

612

2534

1.38

12.13

1.6

1.7

2146.52

1979.80

2.20

597

2480

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

638

2663

1.37

12.05

1.3

1.43

2.10

u/ml

1.16

403

1499

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.31

11.89

2.1

2.0

270.77

237.44

ug/l

0.47

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

509

2049

1.42

11.88

2.3

2.7

1047.93

967.37

u/ml

0.24

504

2021

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

422

1642

1.47

11.78

9.2

6.1

971.58

3678.07

u/ml

0.59

120

280

(3022493) Free Hemoglobin [Mass/volume] in Plasma

376

1430

1.50

11.73

5.3

4.6

570.87

2568.36

mg/l

1.99

287

1015

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

341

1279

1.53

11.37

1.9

2.1

30.16

28.98

0.70

321

1220

(3025577) Chromium [Mass/volume] in Blood

408

1589

1.47

11.36

2.1

2.2

2.11

2.35

ug/l

0.51

343

1321

(3006245) CD3-CD19+ cells/cells in Blood

353

1335

1.51

11.33

2.1

2.3

8.91

10.08

1.31

328

1245

(3044007) Cell count panel - Peritoneal fluid

264

934

1.62

11.30

2.0

1.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1229

5658

1.25

11.28

1.3

3.08

3.58

u/ml

0.56

434

2207

(3001964) Herpes simplex virus Ag [Presence] in Specimen

249

869

1.64

11.25

1.6

1.5

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1199

5514

1.25

11.12

1.3

3.36

4.05

u/ml

1.67

534

2618

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3411

17188

1.14

11.08

3.6

3.3

48.92

51.39

u/ml

0.24

3290

16646

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

651

2765

1.35

11.06

1.2

—

(3028433) Virus identified in Specimen by Culture

267

953

1.60

11.04

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

230

792

1.66

10.95

1.5

1.4

13.33

13.38

g/l

0.02

161

606

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

269

964

1.60

10.95

2.2

2.0

1.84

1.77

ratio

0.28

256

936

(3016228) CD19 cells/cells in Blood

328

1231

1.52

10.93

2.2

2.0

7.40

8.35

0.83

316

1208

(4146454) Self-monitoring of blood glucose

754

3279

1.32

10.91

2.7

2.8

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

246

2.23

10.88

1.4

1.3

10.81

14.83

pmol/l

0.71

198

(3017817) Protein [Mass] in Urine collected for unspecified duration

665

2845

1.34

10.78

2.6

1031.09

1107.09

0.44

659

2815

(3000330) Specific gravity of Urine by Test strip

3143

15789

1.14

10.70

3.7

3.2

1.02

ratio

5.50

2835

14137

(3000060) B lymphocytes [#/volume] in Blood

278

1011

1.57

10.66

1.9

2.1

0.74

0.69

e9/l

0.03

127

475

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1201

5552

1.24

10.65

1.2

0.77

1.12

0.96

258

(4015189) Microbial culture of sputum

207

703

1.68

10.41

2.3

2.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

495

2033

1.39

10.39

1.0

274.44

343.53

ng/l

2.91

384

1470

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

664

2864

1.33

10.22

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

686

2974

1.32

10.19

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

673

2912

1.32

10.14

1.2

—

(3026470) Cobalt [Mass/volume] in Blood

413

1650

1.43

10.14

2.1

2.2

3.17

3.67

ug/l

0.57

384

1521

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

664

2869

1.33

10.10

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

125

367

1.95

10.05

1.2

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

606

2587

1.34

10.01

1.4

1.3

161.80

186.37

pmol/l

1.41

606

2587

(40762365) Oxygen content in Arterial blood by calculation

143

441

1.85

9.96

3.1

3.0

14.82

14.77

ml/dl

0.06

130

416

(3018333) Ribosomal P Ab [Presence] in Serum

627

2693

1.33

9.95

1.1

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

305

1152

1.51

9.93

1.9

1.7

36516.18

17647.37

u/ml

0.24

162

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

600

2562

1.34

9.90

1.2

1.3

82.21

80.74

0.20

168

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

142

438

1.85

9.89

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

291

1089

1.53

9.88

1.1

90.06

90.94

0.11

144

523

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

494

2047

1.38

9.86

1.0

813.92

742.29

ng/l

2.45

362

1438

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

351

1368

1.47

9.82

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

494

2051

1.38

9.75

1.0

41.04

41.00

ng/l

0.00

372

1462

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

576

2453

1.34

9.69

1.4

12.49

12.47

umol/l

0.03

539

2329

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

277

1031

1.54

9.66

1.2

21.95

21.55

0.03

175

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

828

3711

1.28

9.62

1.2

1.1

1.42

1.96

iu/ml

0.41

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

141

439

1.84

9.56

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3829

19617

1.12

9.56

2.3

2.0

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

300

1139

1.51

9.55

1.9

2.7

0.98

1.11

ug/l

0.58

284

1075

(3006571) Granulocytes/Leukocytes in Synovial fluid

869

3925

1.27

9.49

1.5

1.6

57.62

57.26

0.09

558

2479

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

638

2768

1.32

9.47

1.2

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

876

0.47

9.46

6.3

6.9

9.62

8.68

0.66

876

(40761995) Spermatozoa Progressive [#/volume] in Semen

876

0.47

9.46

3.2

3.4

39.25

45.30

1.70

876

(3006270) Folate [Moles/volume] in Blood

569

2432

1.34

9.36

1.2

377.56

367.56

nmol/l

0.52

483

2066

(3052592) Norovirus Ag [Presence] in Stool

164

539

1.74

9.33

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

215

2.21

9.25

1.6

1.9

44.71

47.21

umol/l

0.33

215

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1144

5352

1.22

9.15

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

204

718

1.62

9.03

1.6

1.4

0.27

0.28

mmol/l

0.05

107

(3042733) HLA Ab [Presence] in Serum

304

1172

1.48

9.03

5.3

5.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

509

2152

1.35

9.02

2.6

3.4

26.88

26.20

mu/l

0.15

473

2043

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

240

2.12

9.01

1.1

1.2

0.50

0.57

iu/ml

0.26

120

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

793

3568

1.27

8.97

1.1

—

(3012565) Volume of 24 hour Urine

393

1594

1.41

8.94

2.4

2.1

1966.45

1998.07

0.22

354

1438

(3008536) Aspergillus sp Ab [Presence] in Serum

185

638

1.66

8.87

1.9

2.1

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

265

2.05

8.84

1.6

1.46

1.84

mg/l

0.36

172

(3006576) Bicarbonate [Moles/volume] in Blood

266

1004

1.52

8.76

5.0

6.5

24.83

25.14

mmol/l

0.52

247

910

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

233

2014

0.66

8.75

1.9

1.8

1978.07

448.13

pmol/l

0.35

286

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

259

2.05

8.70

1.6

1.87

1.83

mg/l

0.02

161

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

259

2.05

8.70

1.6

2.02

1.74

mg/l

0.23

183

(4195642) Thrombophilia screening test

1101

5164

1.22

8.62

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

181

626

1.65

8.60

1.3

1.17

1.18

mmol/l

0.51

181

626

(3029396) Erythrocyte agglutination [Presence] in Blood

1040

0.54

8.50

2.6

3.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

166

564

1.68

8.44

1.1

0.71

3.21

umol/24h

0.52

295

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

293

1139

1.47

8.39

1.2

108.60

107.99

0.08

265

1045

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

259

2.03

8.38

1.7

1.6

2.46

2.64

mg/l

0.09

179

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

259

2.03

8.38

1.7

1.6

1.78

2.29

mg/l

0.37

170

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

259

2.03

8.38

1.7

1.6

4.49

3.69

mg/l

0.44

164

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

259

2.03

8.38

1.7

1.6

1.97

2.21

mg/l

0.16

188

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

259

2.03

8.38

1.7

1.6

0.87

0.82

mg/l

0.05

173

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

259

2.03

8.38

1.7

1.6

1.18

1.32

mg/l

0.10

153

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

259

2.03

8.38

1.7

1.6

2.79

2.23

mg/l

0.39

174

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1105

5202

1.22

8.35

1.1

117.97

117.49

0.18

1002

4761

(37208534) Antinuclear antibody arbitrary concentration in serum

286

1108

1.48

8.34

1.0

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

103

303

1.94

8.33

1.2

1.82

1.74

iu/ml

0.18

161

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

333

1330

1.43

8.29

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

124

389

1.82

8.28

1.3

78.34

234.83

u/l

0.67

281

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

288

1119

1.47

8.28

1.1

88.24

90.68

0.50

136

536

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

298

1166

1.46

8.27

1.3

1.2

110.75

110.47

0.05

271

1052

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

674

3004

1.28

8.27

4.6

5.4

99.30

103.03

u/ml

0.05

202

1045

(40761539) Cells [Type] in Urine sediment by Light microscopy

198

710

1.59

8.19

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

235

879

1.53

8.11

1.3

3.69

3.47

mmol/l

0.36

214

812

(3008037) Lactate [Moles/volume] in Venous blood

1570

7653

1.18

8.10

3.8

3.0

1.57

mmol/l

0.01

1533

7478

(3013762) Body weight Measured

2.89

8.04

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

451

1910

1.35

7.97

1.5

1.6

1.23

1.27

nmol/l

0.26

330

1478

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1079

5097

1.21

7.91

1.1

6.96

3.84

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

209

766

1.56

7.90

1.6

0.38

0.40

ug/l

0.32

153

549

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

531

2310

1.32

7.83

1.3

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

672

3016

1.28

7.83

1.4

119626.13

105959.85

e6/l

0.21

431

2017

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

236

893

1.51

7.74

1.5

1.7

10.18

9.08

ug/l

2.41

236

893

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

446

1895

1.35

7.74

1.4

1.3

4.11

4.95

umol/l

5.20

393

1668

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1247

5988

1.19

7.69

1.1

13.86

15.46

au/ml

0.38

283

1698

(3004616) Nuclear Ab [Presence] in Serum

930

4342

1.23

7.67

1.4

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

311

1246

1.43

7.66

1.3

1.2

0.32

0.30

g/l

2.48

246

994

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

101

305

1.89

7.61

1.4

70.73

70.74

0.00

252

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1034

4887

1.21

7.56

1.1

2.53

2.83

0.46

166

872

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

206

764

1.54

7.43

1.2

14.44

11.66

pmol/l

0.50

292

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

430

1830

1.34

7.40

1.2

1.1

82.75

83.55

u/l

0.08

383

1635

(3024471) HLA-A [Type]

277

1094

1.45

7.39

1.0

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

396

1665

1.36

7.38

1.8

1.9

155.63

146.10

1.39

368

1585

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

855

3976

1.23

7.35

1.1

99.60

96.62

2.43

796

3746

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

426

1814

1.34

7.32

1.2

—

(3024932) HLA-DR beta [Type]

271

1068

1.45

7.31

1.1

—

(3002619) Bacteria identified in Specimen by Culture

220

834

1.51

7.20

1.3

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

212

798

1.52

7.17

1.1

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

426

1821

1.34

7.14

1.2

1.1

25.40

22.97

u/l

0.38

376

1629

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

261

1027

1.45

7.12

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1201

5793

1.19

7.08

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

137

465

1.68

7.08

1.3

1.2

1.03

1.28

mmol/l

0.21

299

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

153

2.24

7.04

1.1

1.05

1.22

u/field

0.98

103

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

298

1.86

6.99

1.1

24.10

20.15

u/l

0.90

181

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

143

494

1.65

6.93

1.4

0.20

0.27

nmol/l

1.18

100

342

(3019420) Tryptase [Mass/volume] in Serum or Plasma

459

1993

1.32

6.93

1.5

9.10

8.25

ug/l

0.30

424

1826

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

641

2912

1.26

6.83

1.3

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1480

7292

1.16

6.75

2.4

126.32

108.55

ug/min

0.64

864

4401

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

240

940

1.46

6.73

3.3

3.1

1.79

1.82

ratio

0.10

222

863

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

205

778

1.51

6.71

1.7

1.9

36.65

37.42

u/l

0.02

188

706

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

176

647

1.56

6.66

1.2

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

259

2079

0.71

6.64

1.4

33.39

33.76

nmol/l

0.06

224

1914

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

162

586

1.58

6.57

5.2

7.4

65.87

71.90

1.83

124

452

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

136

471

1.65

6.56

5.6

5.4

51.63

42.95

ug/min

0.76

112

364

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

610

0.48

6.55

1.2

64.02

69.24

ug/l

0.35

610

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

154

552

1.59

6.49

2.4

2.5

6.95

7.58

mmol/l

1.35

105

327

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

129

442

1.67

6.48

1.5

1.6

151825.76

252868.36

nmol/l

0.40

110

367

(3002621) Streptococcal DNAse B [Units/volume] in Serum

294

1.83

6.45

1.0

1.1

562.74

266.50

u/ml

0.76

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

504

2243

1.29

6.38

1.1

0.99

2.10

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

153

2.17

6.33

1.5

1.8

0.82

0.69

umol/l

0.58

123

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

181

678

1.53

6.32

2.6

2.7

360.82

453.13

ug/l

0.12

181

678

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

328

1375

1.36

6.31

2.1

113.71

100.92

ug/min

0.13

317

(3032352) Blasts [#/volume] in Cerebral spinal fluid

106

348

1.74

6.22

1.7

2.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

688

4809

0.82

6.19

1.9

2.2

7.10

7.26

umol/l

0.10

497

3496

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

160

588

1.56

6.10

5.2

6.3

17571.11

3382.77

iu/ml

—

(4212803) Bone marrow aspirate examination

230

1.91

6.09

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

215

842

1.46

6.09

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

211

825

1.46

6.03

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

4529

23970

1.08

5.91

2.4

2.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

335

1428

1.34

5.83

1.1

527.39

318.15

ng/l

0.39

397

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

120

416

1.65

5.82

2.0

2.4

1.21

1.24

mmol/l

0.04

283

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

158

587

1.54

5.77

1.4

1.7

1.51

1.12

nmol/l

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

282

1172

1.38

5.77

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

150

551

1.56

5.76

1.1

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

197

768

1.47

5.74

1.2

1.3

108.73

106.20

0.46

188

729

(44813793) Dust mix specific IgE antibody measurement

536

2441

1.26

5.69

1.1

—

(4268621) Lupus anticoagulant assay

828

3946

1.20

5.69

2.4

2.3

—

(3035285) Chloride [Moles/volume] in Venous blood

725

3416

1.21

5.61

2.7

2.3

105.39

105.74

mmol/l

1.08

719

3387

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

179

688

1.49

5.60

1.2

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

725

3418

1.21

5.58

2.7

2.3

4.06

4.05

mmol/l

0.20

719

3389

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

127

453

1.60

5.54

2.1

2.0

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

286

1200

1.36

5.53

1.7

2.0

180.60

165.69

1.21

273

1136

(3014148) Varicella zoster virus Ab [Titer] in Serum

1004

4881

1.18

5.51

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

148

549

1.54

5.47

1.3

666346.15

10937.82

u/ml

0.47

(3043410) Blood group antigens tested for on Red Blood Cells

212

848

1.43

5.43

1.8

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

140

516

1.55

5.34

1.9

1.8

51.98

46.56

pmol/l

0.27

120

434

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

137

503

1.56

5.31

1.3

1.4

106.34

261.86

ng/l

0.44

326

(3013247) Albumin in CSF/Albumin in Serum or Plasma

194

767

1.45

5.30

1.1

7.01

6.90

mg/g

0.08

185

734

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

205

1.90

5.29

3.6

2.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

208

834

1.43

5.27

1.2

1.3

281.21

241.11

ug/l

0.11

116

442

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

759

3617

1.20

5.25

1.2

48.33

45.81

u/ml

0.09

174

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

315

1.71

5.22

2.9

3.1

1.15

1.36

mg/l

0.51

221

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

197

785

1.43

5.17

1.4

1.3

40.79

39.25

0.21

141

515

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

412

1841

1.28

5.16

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

439

1979

1.27

5.13

1.1

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

249

1.79

5.11

1.2

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

183

723

1.45

5.04

1.1

1.2

80.11

76.55

0.28

193

(3000919) Neutrophils/Leukocytes in Pleural fluid

191

761

1.43

5.03

1.5

1.4

21.92

22.37

0.08

169

694

(3003329) Lymphocytes/Leukocytes in Synovial fluid

640

3017

1.21

4.99

1.5

1.6

32.05

31.40

0.16

393

1891

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

151

576

1.50

4.96

1.1

5.36

44.22

iu/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

140

1183

0.68

4.92

1.1

1.0

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

207

841

1.41

4.91

1.5

1.4

3.61

2.67

0.74

176

710

(3016750) Collection duration of Urine

392

1755

1.28

4.87

2.3

2.2

504.27

497.82

min

0.65

289

1315

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

182

724

1.44

4.85

1.2

86.32

88.97

0.21

203

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

131

487

1.54

4.85

1.0

80.30

82.27

ug/l

0.20

103

384

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

163

1.96

4.85

4.8

5.4

—

(3020393) Adenovirus Ag [Presence] in Stool

344

1.64

4.84

1.2

1.3

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

128

2.10

4.84

1.1

1.3

0.06

0.08

g/l

1.19

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

132

492

1.53

4.83

1.5

1.6

—

(3009015) Lactate [Moles/volume] in Synovial fluid

301

1.69

4.81

1.2

5.60

6.51

mmol/l

0.85

159

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

314

1.67

4.81

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

221

1.81

4.78

1.5

1.4

14.18

16.24

pmol/l

0.51

193

(3035320) C reactive protein [Mass/volume] in Body fluid

551

2572

1.23

4.76

3.4

2.5

25.83

28.84

mg/l

1.10

405

1833

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

122

454

1.54

4.53

1.2

1.3

34.13

43.35

mg/l

1.49

105

384

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

196

1.84

4.52

1.0

—

(3024263) Appearance of Synovial fluid

353

1579

1.28

4.46

1.6

1.7

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

162

642

1.44

4.45

1.3

1.4

26.76

21.66

1.25

133

531

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

291

1271

1.31

4.41

1.1

—

(3008898) HLA-B27 [Presence]

2417

12617

1.10

4.40

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

192

787

1.39

4.38

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

16927

99558

0.96

4.36

1.4

1.5

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1779

9149

1.11

4.36

1.9

1.8

—

(3038026) Centromere Ab [Units/volume] in Serum

549

2588

1.21

4.35

1.2

57.22

56.92

u/ml

0.01

155

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

156

617

1.45

4.34

2.3

1.9

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

215

902

1.36

4.28

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

215

902

1.36

4.28

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

215

902

1.36

4.28

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

215

902

1.36

4.28

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2225

11594

1.10

4.23

1.3

215.96

219.79

miu/ml

0.17

853

5415

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

278

1.66

4.21

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

633

3039

1.19

4.15

1.3

1.2

73.92

68.78

u/ml

0.13

107

(3046861) Legionella sp Ag [Presence] in Urine

194

1.80

4.12

1.1

—

(3001556) Androgen free Index in Serum or Plasma

303

1.62

4.06

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

281

1.65

4.06

1.2

1.1

—

(40768795) Lymph node Pathology biopsy report

665

3214

1.18

4.05

1.3

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.52

4.03

1.9

2.8

1.41

3.16

mu/l

1.12

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

353

1601

1.26

4.03

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

695

3374

1.18

4.02

2.8

2.3

1.20

mmol/l

0.77

689

3345

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

108

403

1.53

4.01

1.8

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

305

1.61

3.96

1.1

1.2

0.11

0.35

u/ml

1.13

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

135

1.95

3.96

12.6

8.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

244

1.69

3.94

1.4

1.2

99.65

101.62

ug/l

0.05

152

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

166

678

1.40

3.92

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

333

1.58

3.91

1.2

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

131

513

1.46

3.88

1.4

1.3

—

(3020491) Glucose [Moles/volume] in Blood

496

2345

1.21

3.87

1.9

1.7

7.20

6.72

mmol/l

2.54

375

1711

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

520

2472

1.20

3.83

2.0

1.9

1.71

2.90

u/field

0.68

293

1386

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

200

1.74

3.77

1.1

45.33

81.62

u/l

0.60

164

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

108

410

1.51

3.74

1.3

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

231

1.68

3.72

4.1

2.9

86.60

73.51

pmol/l

0.08

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

325

1.56

3.67

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.14

3.66

1.2

1.1

0.36

0.03

g/l

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

254

1.64

3.66

2.4

2.3

60.58

59.63

0.07

156

(3025130) Human papilloma virus identified in Specimen

1129

5720

1.13

3.65

1.8

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

259

1.63

3.63

1.2

1.3

17.69

17.08

nmol/l

0.09

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

194

1.74

3.62

7.8

4.5

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

230

1003

1.31

3.61

1.5

1.4

62.48

62.09

0.06

192

824

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

105

401

1.50

3.56

1.0

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

319

1.56

3.54

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

213

924

1.32

3.49

1.3

39.21

40.43

g/l

0.58

106

504

(3034891) Synovial lining cells/cells in Synovial fluid

344

1586

1.24

3.47

1.4

1.5

4.30

3.88

0.14

349

(3039443) Prostate specific Ag panel - Serum or Plasma

942

6090

0.88

3.42

1.6

—

20.32

—

(44806071) Cardiolipin IgM antibody measurement

121

480

1.44

3.41

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

162

678

1.37

3.37

1.2

408.28

294.94

pmol/l

0.56

115

516

(3001686) Cold agglutinin [Titer] in Serum or Plasma

135

549

1.41

3.33

1.3

106.50

349.69

titre

0.81

(1617658) Protocol used for examination of sentinel lymph nodes

462

2208

1.20

3.28

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

190

1416

0.77

3.21

1.1

1.3

1026.67

1032.48

titre

0.02

311

(3045462) Protein/Creatinine [Ratio] in Urine

101

392

1.47

3.21

3.7

4.0

27.72

44.78

mg/mmol

1.34

361

(37021550) Renin [Units/volume] in Plasma --upright

144

597

1.38

3.20

1.2

1.3

67.67

67.93

mu/l

0.01

101

456

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

197

858

1.31

3.18

1.1

—

(3006969) Lambda light chains [Mass/volume] in Urine

2.06

3.16

1.2

1.1

0.03

0.08

g/l

0.57

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

235

0.44

3.16

1.0

1.1

1.29

1.26

mom

0.07

235

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

352

1646

1.22

3.15

1.8

1.7

2.80

2.73

u/field

0.05

269

1175

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

114

1.90

3.15

1.1

1.0

—

(3012898) Urea [Moles/volume] in Urine

352

1.49

3.14

1.6

151.50

174.13

mmol/l

1.12

306

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

316

1462

1.24

3.13

1.1

5.69

9.26

u/ml

1.35

257

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

3.81

3.13

1.3

1.0

96.99

28.12

umol/l

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

409

1943

1.20

3.12

6.5

7.3

16.65

75.30

ug/l

2.20

254

1295

(3013336) Amino acids [Identifier] in Serum or Plasma

2.13

3.11

4.1

2.5

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

182

1.70

3.10

1.0

1.1

1.30

3.40

u/l

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

48498

279423

0.97

3.09

28.6

18.4

332.24

332.65

g/l

18.29

48251

277858

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

300

1.52

3.01

1.1

1.0

0.03

0.04

u/ml

0.87

300

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.04

3.00

4.2

6.4

1.18

1.37

mg/l

0.15

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

113

455

1.42

2.99

1.6

—

(3033086) Enterovirus Ab [Titer] in Serum

1.96

2.99

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

375

1.46

2.98

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

539

2637

1.17

2.96

1.1

7.46

8.34

iu/ml

0.34

143

724

(43055442) Apixaban [Mass/volume] in Serum or Plasma

116

471

1.41

2.94

1.6

125.45

107.01

ug/l

0.80

390

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

2.92

0.0

1.1

—

69.03

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.99

2.92

1.4

1.1

416.69

307.74

pmol/l

0.25

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.94

2.91

1.0

1.1

127.94

237.59

pmol/l

1.76

(3038515) Glucose [Moles/volume] in Venous blood

1238

6398

1.11

2.91

4.1

3.2

7.41

7.58

mmol/l

1.20

1205

6261

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

228

1638

0.79

2.90

1.1

1.2

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

385

1834

1.20

2.89

1.2

—

(40765096) Chromosome analysis panel by Banding

207

921

1.28

2.89

1.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

103

411

1.43

2.88

2.5

3.0

59.15

76.55

pmol/l

0.89

366

(3041806) Other cells [#/volume] in Blood by Manual count

129

997

0.74

2.87

1.6

1.5

0.52

0.51

e9/l

0.21

129

997

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

204

1.62

2.87

1.5

1.7

—

(3049233) Organic acids panel - Urine

2.38

2.85

1.4

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

205

1.62

2.82

1.1

—

(3032641) Amino acids panel - Urine

2.76

2.81

1.3

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

376

1.44

2.79

1.6

1.4

—

(3006598) pH of Arterial cord blood

206

0.44

2.75

1.0

1.1

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

206

0.44

2.75

1.0

6.75

7.16

kpa

0.28

178

(4281824) Cell count and differential, peritoneal fluid

684

3428

1.14

2.74

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1273

6612

1.10

2.74

4.3

3.2

26.50

27.01

mg/l

0.19

893

4530

(1761482) Bacteria [#/volume] in Urine by Culture

1404

7327

1.10

2.73

4.6

3.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

216

1.59

2.72

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

802

4064

1.13

2.71

2.4

2.5

23.93

27.92

iu/ml

0.46

378

(44786800) Granulocytes/Leukocytes in Body fluid

322

1.47

2.70

1.3

23.62

25.22

0.17

243

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.11

2.64

1.2

1.1

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

371

1.43

2.64

2.0

1.7

1.67

1.72

mg/l

0.12

313

(3024316) Viscosity of Plasma

156

1.68

2.63

1.6

1.9

1.59

1.68

mpas

0.25

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.93

2.61

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

251

1.53

2.59

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

309

0.57

2.45

1.0

1.1

0.41

0.92

u/ml

0.61

221

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

232

1071

1.24

2.44

1.2

1.1

3.77

5.35

u/ml

0.43

(40758292) HTLV I+II Ab panel - Serum

144

627

1.31

2.42

1.4

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

228

1.53

2.40

1.0

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1081

5612

1.10

2.40

1.1

10501.58

856.12

iu/ml

0.45

214

1148

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

278

1313

1.21

2.36

2.1

8.44

9.20

mg/l

1.58

224

1089

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.16

2.34

1.3

51.92

60.71

e6/l

0.10

(3004775) Volume in Urine collected for unspecified duration

482

2390

1.15

2.31

2.3

716.27

670.75

1.33

346

1632

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

800

5084

0.90

2.30

3.4

2.4

13.22

13.16

1.04

791

5017

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

109

460

1.35

2.28

1.1

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.84

2.26

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

118

507

1.33

2.21

2.4

2.5

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

400

1.37

2.19

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

357

1.39

2.18

2.4

2.6

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

113

1.72

2.14

1.1

1.4

1.28

1.00

u/field

0.89

(44806420) Estimation of glomerular filtration rate

651

4164

0.89

2.14

2.5

2.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

407

1.36

2.13

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

3.21

2.12

2.7

1.3

—

(3013166) Neutrophils/Leukocytes in Synovial fluid

195

900

1.24

2.11

1.4

53.89

54.11

0.03

159

785

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1415

7484

1.08

2.11

1.4

138.32

129.27

pmol/l

0.25

1378

7314

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

297

1.42

2.10

1.1

1.72

2.97

umol/24h

0.51

297

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

136

1.64

2.08

1.1

2894.17

4558.18

ng/l

0.55

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

260

1.45

2.07

1.2

1.3

1.10

1.48

ml/s/173m2

0.51

170

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

308

1.41

2.06

1.9

1.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

415

1.35

2.05

1.7

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

736

4660

0.90

2.03

1.2

1.3

7.33

7.10

mmol/l

1.09

659

4113

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

5.71

2.02

1.0

324.88

177.30

ug/l

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

113

491

1.31

2.00

1.0

0.30

0.28

u/ml

0.03

314

(3034426) Prothrombin time (PT)

231

1093

1.21

1.99

1.2

27.78

28.18

0.53

231

1093

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.26

1.96

1.0

1.1

24.75

32.50

umol/l

—

(3007147) Virus identified in Stool by Electron microscopy

3.26

1.96

1.0

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

207

1.49

1.96

2.3

19.85

15.60

0.33

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

152

1.58

1.96

1.2

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

198

1.50

1.95

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

3.63

1.94

1.3

1.0

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.74

1.94

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

135

1.61

1.91

1.3

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

209

984

1.21

1.91

1.7

116.98

129.49

au/ml

0.15

133

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

147

0.47

1.90

1.0

0.17

0.53

u/ml

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

322

1577

1.17

1.89

1.2

7.97

12.69

u/ml

0.37

178

(40762814) Titanium [Mass/volume] in Blood

106

461

1.31

1.88

2.3

2.6

3.37

3.63

ug/l

0.30

171

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.81

1.88

1.0

0.27

0.78

u/ml

0.76

(3021162) Amylase [Enzymatic activity/volume] in Specimen

120

531

1.29

1.88

2.7

2.8

2751.35

1342.80

u/l

0.87

106

475

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

363

1.35

1.86

2.4

2.5

0.56

0.57

u/field

0.04

363

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

427

1.32

1.86

1.1

—

(40760409) HLA-A [Type] by High resolution

132

1.60

1.84

1.0

—

(3013862) HLA-DP [Type]

132

1.60

1.84

1.0

—

(40760410) HLA-B [Type] by High resolution

132

1.60

1.84

1.0

—

(46236302) HLA-C [Type] by High resolution typing

132

1.60

1.84

1.0

—

(3051339) Copper [Moles/volume] in Blood

169

1.52

1.81

1.1

1.3

16.72

16.56

umol/l

0.07

145

(3013931) Oligosaccharides [Presence] in Urine

4.76

1.81

1.0

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

168

779

1.23

1.80

1.3

1.1

509.09

510.27

titre

0.00

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

174

1.51

1.80

3.7

3.6

—

(3020650) Glucose [Presence] in Urine

248

1196

1.18

1.78

1.8

1.5

0.05

estimate

0.05

248

1196

(3027974) Hepatitis B virus e Ag [Presence] in Serum

226

1.44

1.78

1.3

1.5

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.75

1.77

1.2

1.3

25.47

49.64

umol/24h

0.79

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

101

441

1.31

1.77

1.6

1.4

10.52

12.55

0.35

228

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

153

704

1.24

1.76

1.1

1.2

37.43

24.07

u/ml

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

107

472

1.30

1.74

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

103

1.66

1.74

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

237

1.42

1.73

1.1

8.98

9.71

u/l

0.16

237

(40763590) HLA-DQ beta [Type]

130

1.58

1.72

1.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

180

846

1.22

1.71

7.7

8.4

5.95

5.97

kpa

0.09

162

757

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1177

6247

1.08

1.68

1.7

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

287

1409

1.16

1.68

1.7

1.6

3302.00

3559.52

titre

0.21

231

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

410

1.31

1.67

7.8

9.1

0.36

0.41

umol/l

0.31

362

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.42

1.67

1.1

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

162

756

1.22

1.66

7.8

8.4

5.76

5.62

kpa

0.26

162

756

(3035611) Eosinophils/Leukocytes in Synovial fluid

192

1.46

1.64

1.6

1.8

0.96

0.63

0.37

148

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

427

2160

1.13

1.64

1.1

1.07

1.06

ratio

1.01

353

1807

(3009677) Dengue virus Ab [Presence] in Serum

132

1.56

1.63

1.1

—

(37019676) Renin [Units/volume] in Plasma --supine

1.84

1.62

1.1

30.77

64.25

mu/l

0.64

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

130

0.48

1.61

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

165

1.49

1.60

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

221

1067

1.18

1.60

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

170

1.48

1.59

11.8

9.9

170.45

320.68

e6/l

0.57

116

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

517

2651

1.11

1.59

2.0

1.8

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

171

1.47

1.55

1.7

2.0

206.62

193.92

ng/l

0.44

149

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

231

1124

1.17

1.54

1.1

1.2

—

(3011544) Albumin [Mass/volume] in Pleural fluid

302

1.34

1.52

1.1

1.2

17.29

17.31

g/l

0.00

276

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

129

595

1.24

1.51

2.5

1.7

5.49

2.91

ug/l

0.31

374

(46235168) Fasting glucose [Moles/volume] in Blood

444

0.73

1.50

2.1

1.8

7.42

7.32

mmol/l

0.06

140

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

187

1.44

1.49

1.0

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

192

1.43

1.48

1.2

454.85

1043.95

u/l

0.56

170

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

294

1463

1.15

1.48

1.1

95.59

97.93

0.70

232

1175

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

119

547

1.24

1.45

5.5

6.8

10.38

10.66

0.54

119

547

(3041184) Isoniazid [Presence] in Urine

2.14

1.44

2.8

2.7

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

184

1.43

1.5

1.9

240.45

160.95

ug/g

1.61

156

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

126

584

1.23

1.42

1.2

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

291

1.33

1.42

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

151

1.48

1.42

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

437

1.27

1.40

1.1

—

(3033942) Copper [Moles/time] in 24 hour Urine

147

1.48

1.40

1.3

1.07

0.54

umol/24h

0.45

(3014599) Egg white IgE Ab [Units/volume] in Serum

367

2354

0.89

1.39

1.0

1.1

2.80

2.38

u/ml

0.14

100

588

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

1.66

1.37

9.3

9.0

43.92

46.23

0.12

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.62

1.37

8.6

9.0

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

111

1.54

1.35

1.2

1.1

2.00

0.99

u/field

0.48

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.44

1.34

1.0

160.00

162.23

g/l

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

141

668

1.21

1.31

1.2

49.45

64.91

mg/l

0.16

109

467

(3015076) Soybean IgE Ab [Units/volume] in Serum

335

2150

0.89

1.30

1.0

1.1

0.58

0.93

u/ml

0.44

502

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.41

1.30

1.0

0.85

11.54

u/ml

—

(3001729) Color of Synovial fluid

227

1.36

1.29

1.5

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

937

4995

1.07

1.27

1.1

3.02

2.97

eliau/ml

0.03

388

2488

(3039744) RNA polymerase III Ab [Units/volume] in Serum

277

1.32

1.27

1.0

1.1

2.67

5.61

u/ml

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

424

1.25

1.4

1.3

57.91

50.54

0.66

202

(3019768) Coxiella burnetii Ab [Presence] in Serum

204

1.37

1.25

1.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.59

1.24

1.0

1.18

3.79

u/ml

1.24

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

451

1.24

1.22

1.2

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.60

1.22

1.3

1.8

176.62

108.42

ug/l

0.67

(3014891) Appearance of Pleural fluid

385

1.26

1.22

1.6

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.90

1.19

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

245

1591

0.88

1.18

1.7

1.74

2.84

u/ml

1.18

432

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

115

1.49

1.18

1.2

1.5

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

120

1.48

1.17

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

413

1.24

1.17

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

493

2573

1.10

1.16

1.1

21.16

19.20

u/ml

0.48

205

1052

(3020874) Milk IgE Ab [Units/volume] in Serum

382

2413

0.90

1.15

1.1

2.37

1.64

u/ml

0.18

133

768

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

126

1.45

1.12

1.0

1.2

229.24

274.68

nmol/l

1.03

126

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

2.35

1.12

1.1

1.2

48.41

28.06

ug/l

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.35

1.12

1.0

1.2

17.27

40.12

nmol/24h

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

224

1.33

1.10

1.3

1.2

2.11

26.13

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

210

1.33

1.08

1.3

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

216

0.69

1.07

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.22

1.07

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

147

1.40

1.06

1.1

1.0

0.09

0.08

0.31

109

(3020123) Porphyrins [Interpretation] in Serum or Plasma

191

1.35

1.06

1.1

—

(3026657) Rickettsia conorii Ab [Titer] in Serum

1.69

1.05

1.0

1.1

—

371.20

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.69

1.05

1.3

1.4

0.75

0.60

u/field

—

(3033099) Centromere Ab [Titer] in Serum

180

892

1.15

1.05

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

827

5035

0.94

1.05

1.1

0.48

0.35

u/ml

0.39

284

1541

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

109

744

0.84

1.04

3.4

2.9

105.75

102.47

ng/l

0.07

387

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

124

1.43

1.02

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

186

0.68

1.01

1.0

0.10

8.08

u/ml

0.53

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.90

1.00

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

193

1.33

1.00

1.1

1.3

0.15

0.16

umol/l

0.97

193

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.66

1.00

1.0

1.1

0.87

0.42

u/ml

0.21

(3027874) Urate [Moles/volume] in Urine

120

1.43

1.00

1.2

1.1

1.54

6.72

mmol/l

0.54

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

2.45

0.98

1.2

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.45

0.98

1.2

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

179

1.34

0.98

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

229

1.30

0.97

1.0

3.90

0.64

u/ml

0.48

214

(3018291) Platelet Ab [Presence] in Serum

1.68

0.97

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

264

0.74

0.97

1.1

1.0

0.15

0.77

u/ml

2.95

144

(3007542) Rye IgE Ab [Units/volume] in Serum

211

0.70

0.97

1.0

0.58

9.60

u/ml

0.49

(3051101) Glucose [Moles/volume] in Cord blood

532

0.82

0.97

5.1

5.5

9.10

8.42

mmol/l

0.49

532

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

206

1.30

0.92

2.0

2.3

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

277

1.26

0.92

1.2

1.1

95.48

96.69

titre

0.04

277

(3036312) Salmon IgE Ab [Units/volume] in Serum

241

0.73

0.91

1.0

1.1

1.62

1.45

u/ml

0.05

163

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.60

0.89

2.0

2.2

22.67

28.68

0.83

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

397

1.21

0.89

1.2

1.3

6.14

5.85

mmol/l

1.99

397

(40762887) Creatinine [Moles/volume] in Blood

243

1.27

0.88

1.6

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

330

0.78

0.88

1.5

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

168

1.33

0.87

1.1

1.4

1.26

1.64

0.25

105

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

134

1.36

0.85

2.0

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

62287

356395

0.98

0.85

33.9

22.2

133.95

136.16

g/l

248.92

61762

353146

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1116

6684

0.95

0.85

1.1

1.17

1.71

u/ml

2.25

566

3296

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.51

0.84

1.4

1.2

—

(3010813) Leukocytes [#/volume] in Blood

62285

356369

0.98

0.82

33.7

22.1

6.90

6.70

e9/l

72.23

61162

348340

(3011829) Common Millet IgE Ab [Units/volume] in Serum

0.00

0.82

0.0

1.0

—

0.10

—

(4211845) Urine protein measurement

303

1582

1.09

0.79

3.0

2.9

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

2.38

0.79

2.8

1.8

—

(36304079) Mucus [Presence] in Urine sediment

2.38

0.79

1.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.52

0.78

2.9

4.8

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

114

751

0.87

0.77

1.1

1.35

1.72

u/ml

0.20

649

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

645

3907

0.94

0.77

1.2

—

(3009992) Blasts/cells in Bone marrow

1.90

0.75

1.7

1.8

16.86

18.38

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

337

1.20

0.75

2.6

2.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

118

1.36

0.74

1.1

1.0

0.03

0.04

u/ml

0.44

118

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

62281

356302

0.98

0.74

34.3

22.5

40.24

41.16

11.89

61720

352852

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

193

0.74

0.73

1.0

25.10

15.26

u/ml

0.23

154

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.82

0.73

1.0

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

62285

356321

0.98

0.73

33.6

22.1

4.43

4.53

e12/l

307.65

61158

348295

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

2.04

0.73

1.0

1.1

—

(3018133) Calcium [Moles/volume] in Urine

132

662

1.14

0.73

2.0

1.8

2.56

2.75

mmol/l

0.52

123

607

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

149

1.30

0.71

1.0

0.11

0.13

u/ml

0.09

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

1.58

0.71

4.4

7.9

49.25

2750.95

e6/l

—

(4034850) Laboratory test

1726

10193

0.97

0.70

13.1

9.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.53

0.70

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

221

1.24

0.69

4.6

5.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

397

2113

1.07

0.69

1.0

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

62284

356290

0.98

0.68

33.6

22.0

91.52

90.84

250.10

61730

353014

(3027035) Albumin [Mass/time] in 24 hour Urine

320

1.20

0.68

1.5

1.3

234.93

351.16

mg/24h

—

(3035941) MCH [Entitic mass]

62282

356276

0.98

0.68

33.5

22.0

30.45

30.28

111.07

61729

353002

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.50

0.67

1.0

1.1

—

(4133840) Spirometry

149

953

0.89

0.67

1.2

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.45

0.65

1.3

6.46

7.66

mg/l

0.11

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.61

0.65

1.0

1.1

4000.55

3691.13

titre

0.14

(3023430) Cat dander IgE Ab [Units/volume] in Serum

945

5633

0.96

0.64

1.1

3.51

4.42

u/ml

1.05

431

2501

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

157

1.27

0.63

1.0

1.1

20.51

21.53

0.72

144

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

198

1.24

0.63

1.4

1.5

10.56

14.18

0.58

136

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.48

0.63

1.9

5.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

137

1.29

0.63

3.1

4.0

—

(3036005) Urine sediment comments by Light microscopy Narrative

1.63

0.62

1.0

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

150

768

1.12

0.62

1.1

23.35

30.08

iu/ml

1.02

150

768

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

597

3235

1.05

0.61

1.3

1.4

9.48

8.48

mmol/l

5.09

554

3087

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

189

1185

0.91

0.61

1.0

9.06

9.10

u/ml

0.01

109

764

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

1.71

0.58

1.2

1.1

18.67

15.40

umol/l

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

139

1.27

0.58

1.0

0.05

0.09

u/ml

0.29

(3013945) Hepatitis B virus e Ab [Presence] in Serum

222

1.21

0.57

1.3

1.4

—

(40768800) Prostate Pathology biopsy report

1153

6357

1.04

0.56

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

266

0.82

0.56

1.0

0.19

0.69

u/ml

0.67

149

(3020356) Listeria sp identified in Specimen by Organism specific culture

228

0.80

0.56

1.2

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

999

5923

0.96

0.56

1.1

3.66

3.90

u/ml

0.15

486

2911

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

171

1.24

0.55

1.0

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.47

0.54

1.0

1.1

—

(3019174) dRVVT (LA screen)

298

1.17

0.52

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

238

0.82

0.52

1.0

1.1

5.62

6.48

u/ml

0.15

141

(3020618) Glucose [Moles/volume] in Synovial fluid

116

1.28

0.51

1.0

1.1

5.88

4.93

mmol/l

0.52

(3029612) Listeria sp Ab [Titer] in Serum

0.64

0.50

1.1

1.4

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

1.60

0.50

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.60

0.50

1.1

1.4

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.60

0.50

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

300

1.16

0.49

1.1

—

(3007461) Platelets [#/volume] in Blood

62279

356143

0.98

0.49

33.7

22.1

253.75

252.28

e9/l

6.12

61329

349218

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

1.54

0.49

1.3

1.0

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

148

1.24

0.49

1.1

207.70

471.19

u/l

1.75

124

(3011335) Digoxin [Mass/volume] in Serum or Plasma

211

1.19

0.48

2.1

2.3

0.69

0.67

ug/l

0.15

211

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

138

1.24

0.48

1.3

1.2

—

(3006462) Nitrate [Presence] in Urine

271

1449

1.07

0.48

3.1

3.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.61

0.47

1.0

1.1

1016.00

2245.74

titre

—

(3022670) pH of Venous cord blood

0.65

0.47

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

288

1748

0.94

0.45

1.3

1.2

9.19

9.90

mm/h

0.58

288

1748

(3006567) Chloride [Moles/time] in 24 hour Urine

1.38

0.45

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

1.36

0.44

1.0

489.00

335.36

umol/l

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

134

699

1.10

0.44

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

134

699

1.10

0.44

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

1.68

0.44

1.0

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

208

0.82

0.44

1.1

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

291

1567

1.06

0.43

2.2

2.5

19.91

197.34

ug/l

1.85

277

1501

(3013466) aPTT in Blood by Coagulation assay

209

1.18

0.42

1.2

1.1

36.49

37.11

0.15

179

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

332

1.14

0.42

1.1

1.0

0.49

5.75

u/ml

0.52

169

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.31

0.41

1.2

1.1

295.29

267.83

u/ml

0.21

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

115

1.24

0.41

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.32

0.41

1.3

1.0

2.13

2.86

0.90

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2202

12329

1.02

0.41

1.5

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

347

0.87

0.41

1.0

1.1

0.34

2.70

u/ml

2.73

260

(3003888) Timothy IgE Ab [Units/volume] in Serum

1206

7076

0.97

0.41

1.1

4.00

4.71

u/ml

0.94

616

3729

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

218

1168

1.07

0.39

2.5

2.7

135.79

145.82

au/ml

0.13

164

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

158

1.19

0.39

1.7

1.5

0.22

0.11

u/l

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.31

0.38

1.0

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

358

2145

0.95

0.38

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

308

1.13

0.38

1.2

—

(4038314) Semen analysis, post vasectomy

247

0.86

0.37

1.2

—

(3026726) Creatinine [Moles/volume] in Specimen

271

1.14

0.37

3.1

2.3

681.19

300.62

umol/l

0.66

262

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

263

1424

1.06

0.35

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

239

0.86

0.35

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

243

1314

1.06

0.34

3.2

3.5

8.67

8.37

mg/l

0.22

194

1056

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

132

699

1.08

0.34

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

153

936

0.93

0.34

1.1

1.15

6.41

u/ml

0.86

538

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

230

1.14

0.34

1.3

1.5

41.14

36.79

0.29

146

(3003577) Lead [Moles/volume] in Blood

317

0.88

0.34

1.3

1.5

0.26

0.35

umol/l

0.29

104

(40763791) Oxygen content in Venous blood by calculation

1.25

0.34

5.9

7.6

12.09

12.26

ml/dl

0.06

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.25

0.34

1.0

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.25

0.33

1.1

1.0

0.05

0.18

u/ml

0.52

(3016273) Islet cell 512 Ab [Units/volume] in Serum

225

1.14

0.33

1.0

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

209

1.15

0.33

1.0

1.1

48.68

28.23

u/ml

0.58

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

209

1.15

0.33

1.0

1.1

19.05

25.27

u/ml

0.39

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1159

6776

0.98

0.33

1.1

0.92

1.00

u/ml

0.17

505

2953

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

334

0.89

0.32

1.3

22.37

20.75

mmol/l

1.45

272

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

151

808

1.07

0.31

1.3

—

(3000285) Sodium [Moles/volume] in Blood

112

593

1.08

0.31

1.2

138.79

138.55

mmol/l

0.24

499

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

489

1.09

0.30

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

1.29

0.28

2.0

1.2

0.90

3.21

mmol/l

1.45

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

164

1.15

0.28

1.5

1.3

1.84

1.68

mg/l

0.36

139

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

1.23

0.27

1.0

0.03

0.14

u/ml

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

520

1.08

0.27

1.1

1.0

17.41

7.46

u/ml

0.63

520

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.29

0.26

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.29

0.26

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.29

0.26

1.9

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.29

0.26

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.29

0.26

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.29

0.26

2.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

176

1.14

0.26

1.6

2.4

2.88

10.79

nmol/l

1.77

167

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.22

0.26

1.3

1.1

1.00

1.26

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.21

0.25

1.1

1.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1394

8096

0.98

0.24

1.1

1.66

1.92

u/ml

0.54

738

4280

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

166

1.14

0.24

1.1

1.0

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.28

0.24

1.1

1.0

0.30

0.13

u/ml

—

(3042045) Bilirubin.total [Moles/volume] in Peritoneal fluid

1.36

0.24

1.0

1.1

85.00

88.06

umol/l

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

248

1.11

0.24

1.0

1.1

14.31

19.22

iu/ml

0.32

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

113

1.16

0.23

1.8

3.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

178

1.12

0.23

15.9

13.3

106.43

104.90

g/l

0.25

178

(3017958) Strawberry IgE Ab [Units/volume] in Serum

115

0.84

0.22

1.1

1.0

0.18

0.11

u/ml

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

108

1.16

0.22

1.0

0.14

0.20

u/ml

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

104

630

0.94

0.21

1.1

1.2

1.80

3.90

u/ml

0.76

410

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

6.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

1.22

0.20

1.0

4.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

3217

18542

0.99

0.20

1.8

1.6

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

351

0.93

0.19

1.0

0.43

0.26

u/ml

0.27

214

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

374

0.93

0.18

1.0

0.48

1.52

u/ml

0.44

177

(3041672) Baker's yeast Ab [Presence] in Serum

181

1.10

0.18

1.0

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.18

0.18

2.3

2.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1966

11110

1.01

0.18

1.5

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.84

0.16

3.6

5.6

0.27

0.25

mmol/l

0.11

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.87

0.16

1.1

1.2

32.59

32.27

mg/24h

0.02

(3034614) HLA Ag [Interpretation]

1.16

0.16

1.2

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.14

0.15

1.1

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

173

1.09

0.14

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

210

0.92

0.13

3.3

3.0

18.48

12.87

0.72

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

333

0.94

0.13

1.0

1.1

0.34

2.86

u/ml

1.91

256

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

467

0.95

0.13

1.3

1.7

5.18

6.07

nmol/l

0.41

447

(40758358) Immune stain study

130

1.10

0.12

1.0

—

(3007916) DNA double strand Ab [Titer] in Serum

409

1.05

0.12

1.4

1.3

152.00

136.05

titre

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2434

13994

0.99

0.11

2.4

2.3

4987.25

5651.35

u/l

0.44

772

5714

(3012989) Citrate [Moles/time] in 24 hour Urine

1.13

0.11

1.2

1.6

1.73

2.07

mmol/24h

0.52

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

364

0.96

0.09

1.0

0.07

0.62

u/ml

1.07

169

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

149

1.07

0.09

1.0

1.1

2.07

0.99

u/ml

0.21

149

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

340

0.96

0.09

1.0

5.10

0.34

u/ml

0.68

158

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.11

0.09

1.2

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.88

0.08

1.5

1.4

318.73

406.58

mg/24h

0.54

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

414

1.03

0.08

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.12

0.08

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

234

1314

1.02

0.08

1.8

1.9

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

207

1203

0.98

0.07

1.0

0.30

0.63

u/ml

2.16

199

1182

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

233

0.96

0.06

1.0

1.1

0.02

0.22

u/ml

2.12

233

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

105

0.92

0.06

1.1

1.0

14.20

11.61

mg/l

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.08

0.06

1.1

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1245

7076

1.01

0.05

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

102

1.06

0.04

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1243

7073

1.00

0.04

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

315

1812

0.99

0.03

1.2

1.4

5.89

5.63

mmol/l

3.43

295

1714

(3022229) Phosphate [Moles/volume] in Urine

194

1.03

0.03

1.6

2.2

16.15

18.19

mmol/l

0.39

161

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

115

1.04

0.02

1.0

7068.67

9608.70

ng/l

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

227

0.98

0.01

1.0

3.22

1.46

u/ml

0.25

175

(3027570) Oxalate [Moles/time] in 24 hour Urine

232

1.01

0.00

1.5

343.17

318.17

umol/24h

0.21

232

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.98

0.00

1.3

—

14.01

—

(40759632) Porphyrins [Mass/mass] in Stool

0.98

0.00

1.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.89

0.00

1.0

1.1

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.98

-0.00

1.0

—

0.05

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint RX_N05C and mortality.

Females

Parameter	HR [95% CI]	p-value
RX_N05C	1.11 [1.04, 1.18]	0.001
Birth year	0.996 [0.99, 1.0]	0.3

During the follow-up period (1.1.1998 — 31.12.2019), 70922 out of 292693 females with RX_N05C died.

Males

Parameter	HR [95% CI]	p-value
RX_N05C	1.566 [1.46, 1.68]	< 0.001
Birth year	0.987 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 67683 out of 212291 males with RX_N05C died.

Mortality risk

Mortality risk for people of age

years, who have RX_N05C.

N-year risk	Females	Males
1	0.083%	0.214%
5	0.599%	1.512%
10	1.465%	4.079%
15	2.854%	7.63%
20	5.057%	12.536%

Relationships between endpoints

↥

Index endpoint: RX_N05C – Use of hypnotics and sedatives

GWS hits: 46

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Use of hypnotics and sedatives

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints